source name	characteristics[organism]	characteristics[organism part]	characteristics[organism part]	characteristics[brodmann area]	characteristics[cell type]	characteristics[age]	characteristics[ancestry category]	characteristics[sex]	characteristics[disease]	characteristics[developmental stage]	characteristics[BRAAK]	characteristics[PMD]	characteristics[biological replicate]	characteristics[Amyloid stage]	characteristics[individual]	assay name	technology type	comment[proteomexchange accession number]	comment[data file]	comment[file uri]	comment[fraction identifier]	comment[instrument]	comment[modification parameters]	comment[modification parameters]	comment[cleavage agent details]	comment[cleavage agent details]	comment[label]	comment[precursor mass tolerance]	comment[fragment mass tolerance]	comment[technical replicate]	comment[batch identifier]	factor value[disease]
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD1	not available	INTSTD1	1 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Dementia with Lewy bodies	not available	3	4.5	18	not available	DLB1	2 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Dementia with Lewy bodies	not available	3	25.5	19	not available	DLB2	3 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	Male	Parkinson's disease with dementia	not available	1	9	25	not available	PDD1	4 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Control	not available	0	34	10	not available	Ctrl1	5 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Control	not available	0	22	11	not available	Ctrl2	6 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	Female	Parkinson's disease with dementia	not available	2	24	26	not available	PDD2	7 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Alzheimer's disease	not available	6	10	1	not available	AD1	8 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	4	24.5	2	not available	AD2	9 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD2	not available	INTSTD2	10 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD1	not available	INTSTD1	1 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Dementia with Lewy bodies	not available	3	4.5	18	not available	DLB1	2 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Dementia with Lewy bodies	not available	3	25.5	19	not available	DLB2	3 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	Male	Parkinson's disease with dementia	not available	1	9	25	not available	PDD1	4 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Control	not available	0	34	10	not available	Ctrl1	5 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Control	not available	0	22	11	not available	Ctrl2	6 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	Female	Parkinson's disease with dementia	not available	2	24	26	not available	PDD2	7 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Alzheimer's disease	not available	6	10	1	not available	AD1	8 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	4	24.5	2	not available	AD2	9 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD2	not available	INTSTD2	10 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD1	not available	INTSTD1	1 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Dementia with Lewy bodies	not available	3	4.5	18	not available	DLB1	2 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Dementia with Lewy bodies	not available	3	25.5	19	not available	DLB2	3 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	Male	Parkinson's disease with dementia	not available	1	9	25	not available	PDD1	4 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Control	not available	0	34	10	not available	Ctrl1	5 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Control	not available	0	22	11	not available	Ctrl2	6 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	Female	Parkinson's disease with dementia	not available	2	24	26	not available	PDD2	7 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Alzheimer's disease	not available	6	10	1	not available	AD1	8 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	4	24.5	2	not available	AD2	9 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD2	not available	INTSTD2	10 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD1	not available	INTSTD1	1 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Dementia with Lewy bodies	not available	3	4.5	18	not available	DLB1	2 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Dementia with Lewy bodies	not available	3	25.5	19	not available	DLB2	3 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	Male	Parkinson's disease with dementia	not available	1	9	25	not available	PDD1	4 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Control	not available	0	34	10	not available	Ctrl1	5 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Control	not available	0	22	11	not available	Ctrl2	6 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	Female	Parkinson's disease with dementia	not available	2	24	26	not available	PDD2	7 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Alzheimer's disease	not available	6	10	1	not available	AD1	8 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	4	24.5	2	not available	AD2	9 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD2	not available	INTSTD2	10 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD1	not available	INTSTD1	1 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Dementia with Lewy bodies	not available	3	4.5	18	not available	DLB1	2 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Dementia with Lewy bodies	not available	3	25.5	19	not available	DLB2	3 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	Male	Parkinson's disease with dementia	not available	1	9	25	not available	PDD1	4 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Control	not available	0	34	10	not available	Ctrl1	5 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Control	not available	0	22	11	not available	Ctrl2	6 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	Female	Parkinson's disease with dementia	not available	2	24	26	not available	PDD2	7 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Alzheimer's disease	not available	6	10	1	not available	AD1	8 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	4	24.5	2	not available	AD2	9 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD2	not available	INTSTD2	10 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD1	not available	INTSTD1	1 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Dementia with Lewy bodies	not available	3	4.5	18	not available	DLB1	2 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Dementia with Lewy bodies	not available	3	25.5	19	not available	DLB2	3 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	Male	Parkinson's disease with dementia	not available	1	9	25	not available	PDD1	4 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Control	not available	0	34	10	not available	Ctrl1	5 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Control	not available	0	22	11	not available	Ctrl2	6 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	Female	Parkinson's disease with dementia	not available	2	24	26	not available	PDD2	7 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Alzheimer's disease	not available	6	10	1	not available	AD1	8 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	4	24.5	2	not available	AD2	9 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD2	not available	INTSTD2	10 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD1	not available	INTSTD1	1 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Dementia with Lewy bodies	not available	3	4.5	18	not available	DLB1	2 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Dementia with Lewy bodies	not available	3	25.5	19	not available	DLB2	3 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	Male	Parkinson's disease with dementia	not available	1	9	25	not available	PDD1	4 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Control	not available	0	34	10	not available	Ctrl1	5 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Control	not available	0	22	11	not available	Ctrl2	6 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	Female	Parkinson's disease with dementia	not available	2	24	26	not available	PDD2	7 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Alzheimer's disease	not available	6	10	1	not available	AD1	8 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	4	24.5	2	not available	AD2	9 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD2	not available	INTSTD2	10 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD1	not available	INTSTD1	1 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Dementia with Lewy bodies	not available	3	4.5	18	not available	DLB1	2 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Dementia with Lewy bodies	not available	3	25.5	19	not available	DLB2	3 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	Male	Parkinson's disease with dementia	not available	1	9	25	not available	PDD1	4 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Control	not available	0	34	10	not available	Ctrl1	5 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Control	not available	0	22	11	not available	Ctrl2	6 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	Female	Parkinson's disease with dementia	not available	2	24	26	not available	PDD2	7 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Alzheimer's disease	not available	6	10	1	not available	AD1	8 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	4	24.5	2	not available	AD2	9 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD2	not available	INTSTD2	10 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD1	not available	INTSTD1	1 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Dementia with Lewy bodies	not available	3	4.5	18	not available	DLB1	2 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Dementia with Lewy bodies	not available	3	25.5	19	not available	DLB2	3 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	Male	Parkinson's disease with dementia	not available	1	9	25	not available	PDD1	4 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Control	not available	0	34	10	not available	Ctrl1	5 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Control	not available	0	22	11	not available	Ctrl2	6 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	Female	Parkinson's disease with dementia	not available	2	24	26	not available	PDD2	7 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Alzheimer's disease	not available	6	10	1	not available	AD1	8 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	4	24.5	2	not available	AD2	9 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD2	not available	INTSTD2	10 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD1	not available	INTSTD1	1 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Dementia with Lewy bodies	not available	3	4.5	18	not available	DLB1	2 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Dementia with Lewy bodies	not available	3	25.5	19	not available	DLB2	3 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	Male	Parkinson's disease with dementia	not available	1	9	25	not available	PDD1	4 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Control	not available	0	34	10	not available	Ctrl1	5 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Control	not available	0	22	11	not available	Ctrl2	6 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	Female	Parkinson's disease with dementia	not available	2	24	26	not available	PDD2	7 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Alzheimer's disease	not available	6	10	1	not available	AD1	8 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	4	24.5	2	not available	AD2	9 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD2	not available	INTSTD2	10 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD1	not available	INTSTD1	1 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Dementia with Lewy bodies	not available	3	4.5	18	not available	DLB1	2 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Dementia with Lewy bodies	not available	3	25.5	19	not available	DLB2	3 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	Male	Parkinson's disease with dementia	not available	1	9	25	not available	PDD1	4 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Control	not available	0	34	10	not available	Ctrl1	5 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Control	not available	0	22	11	not available	Ctrl2	6 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	Female	Parkinson's disease with dementia	not available	2	24	26	not available	PDD2	7 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Alzheimer's disease	not available	6	10	1	not available	AD1	8 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	4	24.5	2	not available	AD2	9 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD2	not available	INTSTD2	10 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD1	not available	INTSTD1	1 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Dementia with Lewy bodies	not available	3	4.5	18	not available	DLB1	2 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Dementia with Lewy bodies	not available	3	25.5	19	not available	DLB2	3 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	Male	Parkinson's disease with dementia	not available	1	9	25	not available	PDD1	4 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Control	not available	0	34	10	not available	Ctrl1	5 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Control	not available	0	22	11	not available	Ctrl2	6 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	Female	Parkinson's disease with dementia	not available	2	24	26	not available	PDD2	7 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Alzheimer's disease	not available	6	10	1	not available	AD1	8 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	4	24.5	2	not available	AD2	9 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD2	not available	INTSTD2	10 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD1	not available	INTSTD1	1 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Dementia with Lewy bodies	not available	3	4.5	18	not available	DLB1	2 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Dementia with Lewy bodies	not available	3	25.5	19	not available	DLB2	3 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	Male	Parkinson's disease with dementia	not available	1	9	25	not available	PDD1	4 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Control	not available	0	34	10	not available	Ctrl1	5 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Control	not available	0	22	11	not available	Ctrl2	6 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	Female	Parkinson's disease with dementia	not available	2	24	26	not available	PDD2	7 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Alzheimer's disease	not available	6	10	1	not available	AD1	8 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	4	24.5	2	not available	AD2	9 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD2	not available	INTSTD2	10 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD1	not available	INTSTD1	1 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Dementia with Lewy bodies	not available	3	4.5	18	not available	DLB1	2 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Dementia with Lewy bodies	not available	3	25.5	19	not available	DLB2	3 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	Male	Parkinson's disease with dementia	not available	1	9	25	not available	PDD1	4 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Control	not available	0	34	10	not available	Ctrl1	5 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Control	not available	0	22	11	not available	Ctrl2	6 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	Female	Parkinson's disease with dementia	not available	2	24	26	not available	PDD2	7 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Alzheimer's disease	not available	6	10	1	not available	AD1	8 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	4	24.5	2	not available	AD2	9 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD2	not available	INTSTD2	10 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD1	not available	INTSTD1	1 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Dementia with Lewy bodies	not available	3	4.5	18	not available	DLB1	2 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Dementia with Lewy bodies	not available	3	25.5	19	not available	DLB2	3 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	Male	Parkinson's disease with dementia	not available	1	9	25	not available	PDD1	4 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Control	not available	0	34	10	not available	Ctrl1	5 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Control	not available	0	22	11	not available	Ctrl2	6 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	Female	Parkinson's disease with dementia	not available	2	24	26	not available	PDD2	7 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Alzheimer's disease	not available	6	10	1	not available	AD1	8 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	4	24.5	2	not available	AD2	9 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD2	not available	INTSTD2	10 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD1	not available	INTSTD1	1 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Dementia with Lewy bodies	not available	3	4.5	18	not available	DLB1	2 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Dementia with Lewy bodies	not available	3	25.5	19	not available	DLB2	3 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	Male	Parkinson's disease with dementia	not available	1	9	25	not available	PDD1	4 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Control	not available	0	34	10	not available	Ctrl1	5 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Control	not available	0	22	11	not available	Ctrl2	6 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	Female	Parkinson's disease with dementia	not available	2	24	26	not available	PDD2	7 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Alzheimer's disease	not available	6	10	1	not available	AD1	8 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	4	24.5	2	not available	AD2	9 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD2	not available	INTSTD2	10 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD1	not available	INTSTD1	1 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Dementia with Lewy bodies	not available	3	4.5	18	not available	DLB1	2 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Dementia with Lewy bodies	not available	3	25.5	19	not available	DLB2	3 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	Male	Parkinson's disease with dementia	not available	1	9	25	not available	PDD1	4 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Control	not available	0	34	10	not available	Ctrl1	5 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Control	not available	0	22	11	not available	Ctrl2	6 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	Female	Parkinson's disease with dementia	not available	2	24	26	not available	PDD2	7 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Alzheimer's disease	not available	6	10	1	not available	AD1	8 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	4	24.5	2	not available	AD2	9 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD2	not available	INTSTD2	10 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD1	not available	INTSTD1	1 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Dementia with Lewy bodies	not available	3	4.5	18	not available	DLB1	2 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Dementia with Lewy bodies	not available	3	25.5	19	not available	DLB2	3 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	Male	Parkinson's disease with dementia	not available	1	9	25	not available	PDD1	4 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Control	not available	0	34	10	not available	Ctrl1	5 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Control	not available	0	22	11	not available	Ctrl2	6 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	Female	Parkinson's disease with dementia	not available	2	24	26	not available	PDD2	7 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Alzheimer's disease	not available	6	10	1	not available	AD1	8 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	4	24.5	2	not available	AD2	9 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD2	not available	INTSTD2	10 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD1	not available	INTSTD1	1 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Dementia with Lewy bodies	not available	3	4.5	18	not available	DLB1	2 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Dementia with Lewy bodies	not available	3	25.5	19	not available	DLB2	3 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	Male	Parkinson's disease with dementia	not available	1	9	25	not available	PDD1	4 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Control	not available	0	34	10	not available	Ctrl1	5 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Control	not available	0	22	11	not available	Ctrl2	6 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	Female	Parkinson's disease with dementia	not available	2	24	26	not available	PDD2	7 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Alzheimer's disease	not available	6	10	1	not available	AD1	8 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	4	24.5	2	not available	AD2	9 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD2	not available	INTSTD2	10 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD1	not available	INTSTD1	1 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Dementia with Lewy bodies	not available	3	4.5	18	not available	DLB1	2 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Dementia with Lewy bodies	not available	3	25.5	19	not available	DLB2	3 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	Male	Parkinson's disease with dementia	not available	1	9	25	not available	PDD1	4 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Control	not available	0	34	10	not available	Ctrl1	5 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Control	not available	0	22	11	not available	Ctrl2	6 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	Female	Parkinson's disease with dementia	not available	2	24	26	not available	PDD2	7 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Alzheimer's disease	not available	6	10	1	not available	AD1	8 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	4	24.5	2	not available	AD2	9 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD2	not available	INTSTD2	10 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD1	not available	INTSTD1	1 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Dementia with Lewy bodies	not available	3	4.5	18	not available	DLB1	2 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Dementia with Lewy bodies	not available	3	25.5	19	not available	DLB2	3 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	Male	Parkinson's disease with dementia	not available	1	9	25	not available	PDD1	4 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Control	not available	0	34	10	not available	Ctrl1	5 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Control	not available	0	22	11	not available	Ctrl2	6 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	Female	Parkinson's disease with dementia	not available	2	24	26	not available	PDD2	7 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Alzheimer's disease	not available	6	10	1	not available	AD1	8 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	4	24.5	2	not available	AD2	9 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD2	not available	INTSTD2	10 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD1	not available	INTSTD1	1 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Dementia with Lewy bodies	not available	3	4.5	18	not available	DLB1	2 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Dementia with Lewy bodies	not available	3	25.5	19	not available	DLB2	3 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	Male	Parkinson's disease with dementia	not available	1	9	25	not available	PDD1	4 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Control	not available	0	34	10	not available	Ctrl1	5 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Control	not available	0	22	11	not available	Ctrl2	6 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	Female	Parkinson's disease with dementia	not available	2	24	26	not available	PDD2	7 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Alzheimer's disease	not available	6	10	1	not available	AD1	8 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	4	24.5	2	not available	AD2	9 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD2	not available	INTSTD2	10 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD1	not available	INTSTD1	1 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Dementia with Lewy bodies	not available	3	4.5	18	not available	DLB1	2 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Dementia with Lewy bodies	not available	3	25.5	19	not available	DLB2	3 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	Male	Parkinson's disease with dementia	not available	1	9	25	not available	PDD1	4 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Control	not available	0	34	10	not available	Ctrl1	5 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Control	not available	0	22	11	not available	Ctrl2	6 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	Female	Parkinson's disease with dementia	not available	2	24	26	not available	PDD2	7 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Alzheimer's disease	not available	6	10	1	not available	AD1	8 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	4	24.5	2	not available	AD2	9 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD2	not available	INTSTD2	10 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD1	not available	INTSTD1	1 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Dementia with Lewy bodies	not available	3	4.5	18	not available	DLB1	2 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Dementia with Lewy bodies	not available	3	25.5	19	not available	DLB2	3 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	Male	Parkinson's disease with dementia	not available	1	9	25	not available	PDD1	4 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Control	not available	0	34	10	not available	Ctrl1	5 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Control	not available	0	22	11	not available	Ctrl2	6 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	Female	Parkinson's disease with dementia	not available	2	24	26	not available	PDD2	7 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Alzheimer's disease	not available	6	10	1	not available	AD1	8 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	4	24.5	2	not available	AD2	9 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD2	not available	INTSTD2	10 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD1	not available	INTSTD1	1 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Dementia with Lewy bodies	not available	3	4.5	18	not available	DLB1	2 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Dementia with Lewy bodies	not available	3	25.5	19	not available	DLB2	3 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	Male	Parkinson's disease with dementia	not available	1	9	25	not available	PDD1	4 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Control	not available	0	34	10	not available	Ctrl1	5 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Control	not available	0	22	11	not available	Ctrl2	6 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	Female	Parkinson's disease with dementia	not available	2	24	26	not available	PDD2	7 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Alzheimer's disease	not available	6	10	1	not available	AD1	8 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	4	24.5	2	not available	AD2	9 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD2	not available	INTSTD2	10 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD1	not available	INTSTD1	1 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Dementia with Lewy bodies	not available	3	4.5	18	not available	DLB1	2 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Dementia with Lewy bodies	not available	3	25.5	19	not available	DLB2	3 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	Male	Parkinson's disease with dementia	not available	1	9	25	not available	PDD1	4 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Control	not available	0	34	10	not available	Ctrl1	5 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Control	not available	0	22	11	not available	Ctrl2	6 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	Female	Parkinson's disease with dementia	not available	2	24	26	not available	PDD2	7 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Alzheimer's disease	not available	6	10	1	not available	AD1	8 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	4	24.5	2	not available	AD2	9 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD2	not available	INTSTD2	10 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD1	not available	INTSTD1	1 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Dementia with Lewy bodies	not available	3	4.5	18	not available	DLB1	2 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Dementia with Lewy bodies	not available	3	25.5	19	not available	DLB2	3 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	Male	Parkinson's disease with dementia	not available	1	9	25	not available	PDD1	4 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Control	not available	0	34	10	not available	Ctrl1	5 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Control	not available	0	22	11	not available	Ctrl2	6 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	Female	Parkinson's disease with dementia	not available	2	24	26	not available	PDD2	7 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Alzheimer's disease	not available	6	10	1	not available	AD1	8 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	4	24.5	2	not available	AD2	9 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD2	not available	INTSTD2	10 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD1	not available	INTSTD1	1 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Dementia with Lewy bodies	not available	3	4.5	18	not available	DLB1	2 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Dementia with Lewy bodies	not available	3	25.5	19	not available	DLB2	3 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	Male	Parkinson's disease with dementia	not available	1	9	25	not available	PDD1	4 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Control	not available	0	34	10	not available	Ctrl1	5 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Control	not available	0	22	11	not available	Ctrl2	6 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	Female	Parkinson's disease with dementia	not available	2	24	26	not available	PDD2	7 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Alzheimer's disease	not available	6	10	1	not available	AD1	8 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	4	24.5	2	not available	AD2	9 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD2	not available	INTSTD2	10 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD1	not available	INTSTD1	1 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Dementia with Lewy bodies	not available	3	4.5	18	not available	DLB1	2 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Dementia with Lewy bodies	not available	3	25.5	19	not available	DLB2	3 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	Male	Parkinson's disease with dementia	not available	1	9	25	not available	PDD1	4 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Control	not available	0	34	10	not available	Ctrl1	5 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Control	not available	0	22	11	not available	Ctrl2	6 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	Female	Parkinson's disease with dementia	not available	2	24	26	not available	PDD2	7 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Alzheimer's disease	not available	6	10	1	not available	AD1	8 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	4	24.5	2	not available	AD2	9 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD2	not available	INTSTD2	10 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD1	not available	INTSTD1	1 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Dementia with Lewy bodies	not available	3	4.5	18	not available	DLB1	2 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Dementia with Lewy bodies	not available	3	25.5	19	not available	DLB2	3 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	Male	Parkinson's disease with dementia	not available	1	9	25	not available	PDD1	4 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Control	not available	0	34	10	not available	Ctrl1	5 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Control	not available	0	22	11	not available	Ctrl2	6 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	Female	Parkinson's disease with dementia	not available	2	24	26	not available	PDD2	7 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Alzheimer's disease	not available	6	10	1	not available	AD1	8 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	4	24.5	2	not available	AD2	9 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD2	not available	INTSTD2	10 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD1	not available	INTSTD1	1 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Dementia with Lewy bodies	not available	3	4.5	18	not available	DLB1	2 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Dementia with Lewy bodies	not available	3	25.5	19	not available	DLB2	3 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	Male	Parkinson's disease with dementia	not available	1	9	25	not available	PDD1	4 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Control	not available	0	34	10	not available	Ctrl1	5 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Control	not available	0	22	11	not available	Ctrl2	6 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	Female	Parkinson's disease with dementia	not available	2	24	26	not available	PDD2	7 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Alzheimer's disease	not available	6	10	1	not available	AD1	8 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	4	24.5	2	not available	AD2	9 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD2	not available	INTSTD2	10 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD1	not available	INTSTD1	1 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Dementia with Lewy bodies	not available	3	4.5	18	not available	DLB1	2 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Dementia with Lewy bodies	not available	3	25.5	19	not available	DLB2	3 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	Male	Parkinson's disease with dementia	not available	1	9	25	not available	PDD1	4 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Control	not available	0	34	10	not available	Ctrl1	5 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Control	not available	0	22	11	not available	Ctrl2	6 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	Female	Parkinson's disease with dementia	not available	2	24	26	not available	PDD2	7 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Alzheimer's disease	not available	6	10	1	not available	AD1	8 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	4	24.5	2	not available	AD2	9 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD2	not available	INTSTD2	10 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD1	not available	INTSTD1	1 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Dementia with Lewy bodies	not available	3	4.5	18	not available	DLB1	2 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Dementia with Lewy bodies	not available	3	25.5	19	not available	DLB2	3 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	Male	Parkinson's disease with dementia	not available	1	9	25	not available	PDD1	4 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Control	not available	0	34	10	not available	Ctrl1	5 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Control	not available	0	22	11	not available	Ctrl2	6 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	Female	Parkinson's disease with dementia	not available	2	24	26	not available	PDD2	7 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Alzheimer's disease	not available	6	10	1	not available	AD1	8 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	4	24.5	2	not available	AD2	9 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD2	not available	INTSTD2	10 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD1	not available	INTSTD1	1 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Dementia with Lewy bodies	not available	3	4.5	18	not available	DLB1	2 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Dementia with Lewy bodies	not available	3	25.5	19	not available	DLB2	3 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	Male	Parkinson's disease with dementia	not available	1	9	25	not available	PDD1	4 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Control	not available	0	34	10	not available	Ctrl1	5 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Control	not available	0	22	11	not available	Ctrl2	6 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	Female	Parkinson's disease with dementia	not available	2	24	26	not available	PDD2	7 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Alzheimer's disease	not available	6	10	1	not available	AD1	8 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	4	24.5	2	not available	AD2	9 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD2	not available	INTSTD2	10 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD1	not available	INTSTD1	1 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Dementia with Lewy bodies	not available	3	4.5	18	not available	DLB1	2 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Dementia with Lewy bodies	not available	3	25.5	19	not available	DLB2	3 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	Male	Parkinson's disease with dementia	not available	1	9	25	not available	PDD1	4 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Control	not available	0	34	10	not available	Ctrl1	5 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Control	not available	0	22	11	not available	Ctrl2	6 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	Female	Parkinson's disease with dementia	not available	2	24	26	not available	PDD2	7 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Alzheimer's disease	not available	6	10	1	not available	AD1	8 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	4	24.5	2	not available	AD2	9 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD2	not available	INTSTD2	10 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD1	not available	INTSTD1	1 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Dementia with Lewy bodies	not available	3	4.5	18	not available	DLB1	2 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Dementia with Lewy bodies	not available	3	25.5	19	not available	DLB2	3 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	Male	Parkinson's disease with dementia	not available	1	9	25	not available	PDD1	4 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Control	not available	0	34	10	not available	Ctrl1	5 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Control	not available	0	22	11	not available	Ctrl2	6 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	Female	Parkinson's disease with dementia	not available	2	24	26	not available	PDD2	7 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Alzheimer's disease	not available	6	10	1	not available	AD1	8 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	4	24.5	2	not available	AD2	9 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD2	not available	INTSTD2	10 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD1	not available	INTSTD1	1 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Dementia with Lewy bodies	not available	3	4.5	18	not available	DLB1	2 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Dementia with Lewy bodies	not available	3	25.5	19	not available	DLB2	3 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	Male	Parkinson's disease with dementia	not available	1	9	25	not available	PDD1	4 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Control	not available	0	34	10	not available	Ctrl1	5 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Control	not available	0	22	11	not available	Ctrl2	6 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	Female	Parkinson's disease with dementia	not available	2	24	26	not available	PDD2	7 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Alzheimer's disease	not available	6	10	1	not available	AD1	8 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	4	24.5	2	not available	AD2	9 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD2	not available	INTSTD2	10 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD1	not available	INTSTD1	1 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Dementia with Lewy bodies	not available	3	4.5	18	not available	DLB1	2 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Dementia with Lewy bodies	not available	3	25.5	19	not available	DLB2	3 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	Male	Parkinson's disease with dementia	not available	1	9	25	not available	PDD1	4 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Control	not available	0	34	10	not available	Ctrl1	5 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Control	not available	0	22	11	not available	Ctrl2	6 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	Female	Parkinson's disease with dementia	not available	2	24	26	not available	PDD2	7 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Alzheimer's disease	not available	6	10	1	not available	AD1	8 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	4	24.5	2	not available	AD2	9 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD2	not available	INTSTD2	10 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD1	not available	INTSTD1	1 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Dementia with Lewy bodies	not available	3	4.5	18	not available	DLB1	2 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Dementia with Lewy bodies	not available	3	25.5	19	not available	DLB2	3 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	Male	Parkinson's disease with dementia	not available	1	9	25	not available	PDD1	4 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Control	not available	0	34	10	not available	Ctrl1	5 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Control	not available	0	22	11	not available	Ctrl2	6 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	Female	Parkinson's disease with dementia	not available	2	24	26	not available	PDD2	7 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Alzheimer's disease	not available	6	10	1	not available	AD1	8 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	4	24.5	2	not available	AD2	9 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD2	not available	INTSTD2	10 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD1	not available	INTSTD1	1 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Dementia with Lewy bodies	not available	3	4.5	18	not available	DLB1	2 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Dementia with Lewy bodies	not available	3	25.5	19	not available	DLB2	3 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	Male	Parkinson's disease with dementia	not available	1	9	25	not available	PDD1	4 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Control	not available	0	34	10	not available	Ctrl1	5 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Control	not available	0	22	11	not available	Ctrl2	6 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	Female	Parkinson's disease with dementia	not available	2	24	26	not available	PDD2	7 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Alzheimer's disease	not available	6	10	1	not available	AD1	8 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	4	24.5	2	not available	AD2	9 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD2	not available	INTSTD2	10 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD1	not available	INTSTD1	1 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Dementia with Lewy bodies	not available	3	4.5	18	not available	DLB1	2 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Dementia with Lewy bodies	not available	3	25.5	19	not available	DLB2	3 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	Male	Parkinson's disease with dementia	not available	1	9	25	not available	PDD1	4 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Control	not available	0	34	10	not available	Ctrl1	5 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Control	not available	0	22	11	not available	Ctrl2	6 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	Female	Parkinson's disease with dementia	not available	2	24	26	not available	PDD2	7 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Alzheimer's disease	not available	6	10	1	not available	AD1	8 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	4	24.5	2	not available	AD2	9 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD2	not available	INTSTD2	10 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD1	not available	INTSTD1	1 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Dementia with Lewy bodies	not available	3	4.5	18	not available	DLB1	2 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Dementia with Lewy bodies	not available	3	25.5	19	not available	DLB2	3 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	Male	Parkinson's disease with dementia	not available	1	9	25	not available	PDD1	4 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Control	not available	0	34	10	not available	Ctrl1	5 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Control	not available	0	22	11	not available	Ctrl2	6 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	Female	Parkinson's disease with dementia	not available	2	24	26	not available	PDD2	7 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Alzheimer's disease	not available	6	10	1	not available	AD1	8 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	4	24.5	2	not available	AD2	9 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD2	not available	INTSTD2	10 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD1	not available	INTSTD1	1 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Dementia with Lewy bodies	not available	3	4.5	18	not available	DLB1	2 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Dementia with Lewy bodies	not available	3	25.5	19	not available	DLB2	3 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	Male	Parkinson's disease with dementia	not available	1	9	25	not available	PDD1	4 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Control	not available	0	34	10	not available	Ctrl1	5 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Control	not available	0	22	11	not available	Ctrl2	6 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	Female	Parkinson's disease with dementia	not available	2	24	26	not available	PDD2	7 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Alzheimer's disease	not available	6	10	1	not available	AD1	8 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	4	24.5	2	not available	AD2	9 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD2	not available	INTSTD2	10 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD1	not available	INTSTD1	1 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Dementia with Lewy bodies	not available	3	4.5	18	not available	DLB1	2 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Dementia with Lewy bodies	not available	3	25.5	19	not available	DLB2	3 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	Male	Parkinson's disease with dementia	not available	1	9	25	not available	PDD1	4 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Control	not available	0	34	10	not available	Ctrl1	5 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Control	not available	0	22	11	not available	Ctrl2	6 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	Female	Parkinson's disease with dementia	not available	2	24	26	not available	PDD2	7 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Alzheimer's disease	not available	6	10	1	not available	AD1	8 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	4	24.5	2	not available	AD2	9 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD2	not available	INTSTD2	10 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD1	not available	INTSTD1	1 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Dementia with Lewy bodies	not available	3	4.5	18	not available	DLB1	2 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Dementia with Lewy bodies	not available	3	25.5	19	not available	DLB2	3 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	Male	Parkinson's disease with dementia	not available	1	9	25	not available	PDD1	4 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Control	not available	0	34	10	not available	Ctrl1	5 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Control	not available	0	22	11	not available	Ctrl2	6 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	Female	Parkinson's disease with dementia	not available	2	24	26	not available	PDD2	7 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Alzheimer's disease	not available	6	10	1	not available	AD1	8 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	4	24.5	2	not available	AD2	9 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD2	not available	INTSTD2	10 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD1	not available	INTSTD1	1 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Dementia with Lewy bodies	not available	3	4.5	18	not available	DLB1	2 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Dementia with Lewy bodies	not available	3	25.5	19	not available	DLB2	3 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	Male	Parkinson's disease with dementia	not available	1	9	25	not available	PDD1	4 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Control	not available	0	34	10	not available	Ctrl1	5 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Control	not available	0	22	11	not available	Ctrl2	6 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	Female	Parkinson's disease with dementia	not available	2	24	26	not available	PDD2	7 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Alzheimer's disease	not available	6	10	1	not available	AD1	8 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	4	24.5	2	not available	AD2	9 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD2	not available	INTSTD2	10 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD1	not available	INTSTD1	1 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Dementia with Lewy bodies	not available	3	4.5	18	not available	DLB1	2 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Dementia with Lewy bodies	not available	3	25.5	19	not available	DLB2	3 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	Male	Parkinson's disease with dementia	not available	1	9	25	not available	PDD1	4 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Control	not available	0	34	10	not available	Ctrl1	5 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Control	not available	0	22	11	not available	Ctrl2	6 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	Female	Parkinson's disease with dementia	not available	2	24	26	not available	PDD2	7 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Alzheimer's disease	not available	6	10	1	not available	AD1	8 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	4	24.5	2	not available	AD2	9 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD2	not available	INTSTD2	10 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD1	not available	INTSTD1	1 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Dementia with Lewy bodies	not available	3	4.5	18	not available	DLB1	2 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Dementia with Lewy bodies	not available	3	25.5	19	not available	DLB2	3 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	Male	Parkinson's disease with dementia	not available	1	9	25	not available	PDD1	4 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Control	not available	0	34	10	not available	Ctrl1	5 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Control	not available	0	22	11	not available	Ctrl2	6 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	Female	Parkinson's disease with dementia	not available	2	24	26	not available	PDD2	7 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Alzheimer's disease	not available	6	10	1	not available	AD1	8 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	4	24.5	2	not available	AD2	9 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD2	not available	INTSTD2	10 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD1	not available	INTSTD1	1 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Dementia with Lewy bodies	not available	3	4.5	18	not available	DLB1	2 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Dementia with Lewy bodies	not available	3	25.5	19	not available	DLB2	3 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	Male	Parkinson's disease with dementia	not available	1	9	25	not available	PDD1	4 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Control	not available	0	34	10	not available	Ctrl1	5 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Control	not available	0	22	11	not available	Ctrl2	6 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	Female	Parkinson's disease with dementia	not available	2	24	26	not available	PDD2	7 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Alzheimer's disease	not available	6	10	1	not available	AD1	8 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	4	24.5	2	not available	AD2	9 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD2	not available	INTSTD2	10 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD1	not available	INTSTD1	1 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Dementia with Lewy bodies	not available	3	4.5	18	not available	DLB1	2 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Dementia with Lewy bodies	not available	3	25.5	19	not available	DLB2	3 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	Male	Parkinson's disease with dementia	not available	1	9	25	not available	PDD1	4 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Control	not available	0	34	10	not available	Ctrl1	5 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Control	not available	0	22	11	not available	Ctrl2	6 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	Female	Parkinson's disease with dementia	not available	2	24	26	not available	PDD2	7 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Alzheimer's disease	not available	6	10	1	not available	AD1	8 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	4	24.5	2	not available	AD2	9 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD2	not available	INTSTD2	10 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD1	not available	INTSTD1	1 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Dementia with Lewy bodies	not available	3	4.5	18	not available	DLB1	2 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Dementia with Lewy bodies	not available	3	25.5	19	not available	DLB2	3 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	Male	Parkinson's disease with dementia	not available	1	9	25	not available	PDD1	4 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Control	not available	0	34	10	not available	Ctrl1	5 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Control	not available	0	22	11	not available	Ctrl2	6 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	Female	Parkinson's disease with dementia	not available	2	24	26	not available	PDD2	7 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Alzheimer's disease	not available	6	10	1	not available	AD1	8 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	4	24.5	2	not available	AD2	9 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD2	not available	INTSTD2	10 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD1	not available	INTSTD1	1 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Dementia with Lewy bodies	not available	3	4.5	18	not available	DLB1	2 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Dementia with Lewy bodies	not available	3	25.5	19	not available	DLB2	3 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	Male	Parkinson's disease with dementia	not available	1	9	25	not available	PDD1	4 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Control	not available	0	34	10	not available	Ctrl1	5 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Control	not available	0	22	11	not available	Ctrl2	6 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	Female	Parkinson's disease with dementia	not available	2	24	26	not available	PDD2	7 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Alzheimer's disease	not available	6	10	1	not available	AD1	8 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	4	24.5	2	not available	AD2	9 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD2	not available	INTSTD2	10 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD1	not available	INTSTD1	1 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Dementia with Lewy bodies	not available	3	4.5	18	not available	DLB1	2 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Dementia with Lewy bodies	not available	3	25.5	19	not available	DLB2	3 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	Male	Parkinson's disease with dementia	not available	1	9	25	not available	PDD1	4 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Control	not available	0	34	10	not available	Ctrl1	5 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Control	not available	0	22	11	not available	Ctrl2	6 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	Female	Parkinson's disease with dementia	not available	2	24	26	not available	PDD2	7 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Alzheimer's disease	not available	6	10	1	not available	AD1	8 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	4	24.5	2	not available	AD2	9 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD2	not available	INTSTD2	10 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD1	not available	INTSTD1	1 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Dementia with Lewy bodies	not available	3	4.5	18	not available	DLB1	2 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Dementia with Lewy bodies	not available	3	25.5	19	not available	DLB2	3 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	Male	Parkinson's disease with dementia	not available	1	9	25	not available	PDD1	4 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Control	not available	0	34	10	not available	Ctrl1	5 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Control	not available	0	22	11	not available	Ctrl2	6 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	Female	Parkinson's disease with dementia	not available	2	24	26	not available	PDD2	7 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Alzheimer's disease	not available	6	10	1	not available	AD1	8 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	4	24.5	2	not available	AD2	9 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD2	not available	INTSTD2	10 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD1	not available	INTSTD1	1 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Dementia with Lewy bodies	not available	3	4.5	18	not available	DLB1	2 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Dementia with Lewy bodies	not available	3	25.5	19	not available	DLB2	3 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	Male	Parkinson's disease with dementia	not available	1	9	25	not available	PDD1	4 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Control	not available	0	34	10	not available	Ctrl1	5 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Control	not available	0	22	11	not available	Ctrl2	6 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	Female	Parkinson's disease with dementia	not available	2	24	26	not available	PDD2	7 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Alzheimer's disease	not available	6	10	1	not available	AD1	8 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	4	24.5	2	not available	AD2	9 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD2	not available	INTSTD2	10 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD1	not available	INTSTD1	1 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Dementia with Lewy bodies	not available	3	4.5	18	not available	DLB1	2 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Dementia with Lewy bodies	not available	3	25.5	19	not available	DLB2	3 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	Male	Parkinson's disease with dementia	not available	1	9	25	not available	PDD1	4 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Control	not available	0	34	10	not available	Ctrl1	5 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Control	not available	0	22	11	not available	Ctrl2	6 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	Female	Parkinson's disease with dementia	not available	2	24	26	not available	PDD2	7 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Alzheimer's disease	not available	6	10	1	not available	AD1	8 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	4	24.5	2	not available	AD2	9 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD2	not available	INTSTD2	10 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD1	not available	INTSTD1	1 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Dementia with Lewy bodies	not available	3	4.5	18	not available	DLB1	2 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Dementia with Lewy bodies	not available	3	25.5	19	not available	DLB2	3 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	Male	Parkinson's disease with dementia	not available	1	9	25	not available	PDD1	4 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Control	not available	0	34	10	not available	Ctrl1	5 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Control	not available	0	22	11	not available	Ctrl2	6 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	Female	Parkinson's disease with dementia	not available	2	24	26	not available	PDD2	7 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Alzheimer's disease	not available	6	10	1	not available	AD1	8 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	4	24.5	2	not available	AD2	9 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD2	not available	INTSTD2	10 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD1	not available	INTSTD1	1 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Dementia with Lewy bodies	not available	3	4.5	18	not available	DLB1	2 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Dementia with Lewy bodies	not available	3	25.5	19	not available	DLB2	3 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	Male	Parkinson's disease with dementia	not available	1	9	25	not available	PDD1	4 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Control	not available	0	34	10	not available	Ctrl1	5 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Control	not available	0	22	11	not available	Ctrl2	6 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	Female	Parkinson's disease with dementia	not available	2	24	26	not available	PDD2	7 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Alzheimer's disease	not available	6	10	1	not available	AD1	8 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	4	24.5	2	not available	AD2	9 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD2	not available	INTSTD2	10 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD1	not available	INTSTD1	1 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Dementia with Lewy bodies	not available	3	4.5	18	not available	DLB1	2 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Dementia with Lewy bodies	not available	3	25.5	19	not available	DLB2	3 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	Male	Parkinson's disease with dementia	not available	1	9	25	not available	PDD1	4 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Control	not available	0	34	10	not available	Ctrl1	5 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Control	not available	0	22	11	not available	Ctrl2	6 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	Female	Parkinson's disease with dementia	not available	2	24	26	not available	PDD2	7 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Alzheimer's disease	not available	6	10	1	not available	AD1	8 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	4	24.5	2	not available	AD2	9 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD2	not available	INTSTD2	10 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD1	not available	INTSTD1	1 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Dementia with Lewy bodies	not available	3	4.5	18	not available	DLB1	2 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Dementia with Lewy bodies	not available	3	25.5	19	not available	DLB2	3 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	Male	Parkinson's disease with dementia	not available	1	9	25	not available	PDD1	4 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Control	not available	0	34	10	not available	Ctrl1	5 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Control	not available	0	22	11	not available	Ctrl2	6 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	Female	Parkinson's disease with dementia	not available	2	24	26	not available	PDD2	7 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Alzheimer's disease	not available	6	10	1	not available	AD1	8 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	4	24.5	2	not available	AD2	9 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD2	not available	INTSTD2	10 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD1	not available	INTSTD1	1 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Dementia with Lewy bodies	not available	3	4.5	18	not available	DLB1	2 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Dementia with Lewy bodies	not available	3	25.5	19	not available	DLB2	3 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	Male	Parkinson's disease with dementia	not available	1	9	25	not available	PDD1	4 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Control	not available	0	34	10	not available	Ctrl1	5 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Control	not available	0	22	11	not available	Ctrl2	6 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	Female	Parkinson's disease with dementia	not available	2	24	26	not available	PDD2	7 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Alzheimer's disease	not available	6	10	1	not available	AD1	8 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	4	24.5	2	not available	AD2	9 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD2	not available	INTSTD2	10 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD1	not available	INTSTD1	1 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Dementia with Lewy bodies	not available	3	4.5	18	not available	DLB1	2 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Dementia with Lewy bodies	not available	3	25.5	19	not available	DLB2	3 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	Male	Parkinson's disease with dementia	not available	1	9	25	not available	PDD1	4 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Control	not available	0	34	10	not available	Ctrl1	5 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Control	not available	0	22	11	not available	Ctrl2	6 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	Female	Parkinson's disease with dementia	not available	2	24	26	not available	PDD2	7 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Alzheimer's disease	not available	6	10	1	not available	AD1	8 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	4	24.5	2	not available	AD2	9 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD2	not available	INTSTD2	10 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD1	not available	INTSTD1	1 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Dementia with Lewy bodies	not available	3	4.5	18	not available	DLB1	2 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Dementia with Lewy bodies	not available	3	25.5	19	not available	DLB2	3 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	Male	Parkinson's disease with dementia	not available	1	9	25	not available	PDD1	4 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Control	not available	0	34	10	not available	Ctrl1	5 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Control	not available	0	22	11	not available	Ctrl2	6 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	Female	Parkinson's disease with dementia	not available	2	24	26	not available	PDD2	7 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Alzheimer's disease	not available	6	10	1	not available	AD1	8 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	4	24.5	2	not available	AD2	9 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD2	not available	INTSTD2	10 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD1	not available	INTSTD1	1 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Dementia with Lewy bodies	not available	3	4.5	18	not available	DLB1	2 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Dementia with Lewy bodies	not available	3	25.5	19	not available	DLB2	3 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	Male	Parkinson's disease with dementia	not available	1	9	25	not available	PDD1	4 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Control	not available	0	34	10	not available	Ctrl1	5 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Control	not available	0	22	11	not available	Ctrl2	6 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	Female	Parkinson's disease with dementia	not available	2	24	26	not available	PDD2	7 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Alzheimer's disease	not available	6	10	1	not available	AD1	8 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	4	24.5	2	not available	AD2	9 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD2	not available	INTSTD2	10 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD1	not available	INTSTD1	1 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Dementia with Lewy bodies	not available	3	4.5	18	not available	DLB1	2 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Dementia with Lewy bodies	not available	3	25.5	19	not available	DLB2	3 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	Male	Parkinson's disease with dementia	not available	1	9	25	not available	PDD1	4 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Control	not available	0	34	10	not available	Ctrl1	5 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Control	not available	0	22	11	not available	Ctrl2	6 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	Female	Parkinson's disease with dementia	not available	2	24	26	not available	PDD2	7 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Alzheimer's disease	not available	6	10	1	not available	AD1	8 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	4	24.5	2	not available	AD2	9 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD2	not available	INTSTD2	10 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD1	not available	INTSTD1	1 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Dementia with Lewy bodies	not available	3	4.5	18	not available	DLB1	2 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Dementia with Lewy bodies	not available	3	25.5	19	not available	DLB2	3 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	Male	Parkinson's disease with dementia	not available	1	9	25	not available	PDD1	4 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Control	not available	0	34	10	not available	Ctrl1	5 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Control	not available	0	22	11	not available	Ctrl2	6 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	Female	Parkinson's disease with dementia	not available	2	24	26	not available	PDD2	7 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Alzheimer's disease	not available	6	10	1	not available	AD1	8 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	4	24.5	2	not available	AD2	9 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD2	not available	INTSTD2	10 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD1	not available	INTSTD1	1 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Dementia with Lewy bodies	not available	3	4.5	18	not available	DLB1	2 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Dementia with Lewy bodies	not available	3	25.5	19	not available	DLB2	3 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	Male	Parkinson's disease with dementia	not available	1	9	25	not available	PDD1	4 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Control	not available	0	34	10	not available	Ctrl1	5 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Control	not available	0	22	11	not available	Ctrl2	6 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	Female	Parkinson's disease with dementia	not available	2	24	26	not available	PDD2	7 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Alzheimer's disease	not available	6	10	1	not available	AD1	8 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	4	24.5	2	not available	AD2	9 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD2	not available	INTSTD2	10 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD1	not available	INTSTD1	1 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Dementia with Lewy bodies	not available	3	4.5	18	not available	DLB1	2 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Dementia with Lewy bodies	not available	3	25.5	19	not available	DLB2	3 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	Male	Parkinson's disease with dementia	not available	1	9	25	not available	PDD1	4 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Control	not available	0	34	10	not available	Ctrl1	5 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Control	not available	0	22	11	not available	Ctrl2	6 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	Female	Parkinson's disease with dementia	not available	2	24	26	not available	PDD2	7 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Alzheimer's disease	not available	6	10	1	not available	AD1	8 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	4	24.5	2	not available	AD2	9 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD2	not available	INTSTD2	10 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD1	not available	INTSTD1	1 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Dementia with Lewy bodies	not available	3	4.5	18	not available	DLB1	2 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Dementia with Lewy bodies	not available	3	25.5	19	not available	DLB2	3 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	Male	Parkinson's disease with dementia	not available	1	9	25	not available	PDD1	4 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Control	not available	0	34	10	not available	Ctrl1	5 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Control	not available	0	22	11	not available	Ctrl2	6 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	Female	Parkinson's disease with dementia	not available	2	24	26	not available	PDD2	7 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Alzheimer's disease	not available	6	10	1	not available	AD1	8 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	4	24.5	2	not available	AD2	9 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD2	not available	INTSTD2	10 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD1	not available	INTSTD1	1 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Dementia with Lewy bodies	not available	3	4.5	18	not available	DLB1	2 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Dementia with Lewy bodies	not available	3	25.5	19	not available	DLB2	3 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	Male	Parkinson's disease with dementia	not available	1	9	25	not available	PDD1	4 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Control	not available	0	34	10	not available	Ctrl1	5 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Control	not available	0	22	11	not available	Ctrl2	6 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	Female	Parkinson's disease with dementia	not available	2	24	26	not available	PDD2	7 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Alzheimer's disease	not available	6	10	1	not available	AD1	8 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	4	24.5	2	not available	AD2	9 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD2	not available	INTSTD2	10 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD1	not available	INTSTD1	1 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Dementia with Lewy bodies	not available	3	4.5	18	not available	DLB1	2 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Dementia with Lewy bodies	not available	3	25.5	19	not available	DLB2	3 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	Male	Parkinson's disease with dementia	not available	1	9	25	not available	PDD1	4 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Control	not available	0	34	10	not available	Ctrl1	5 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Control	not available	0	22	11	not available	Ctrl2	6 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	Female	Parkinson's disease with dementia	not available	2	24	26	not available	PDD2	7 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Alzheimer's disease	not available	6	10	1	not available	AD1	8 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	4	24.5	2	not available	AD2	9 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD2	not available	INTSTD2	10 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD1	not available	INTSTD1	1 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Dementia with Lewy bodies	not available	3	4.5	18	not available	DLB1	2 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Dementia with Lewy bodies	not available	3	25.5	19	not available	DLB2	3 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	1	Dementia with Lewy bodies
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	Male	Parkinson's disease with dementia	not available	1	9	25	not available	PDD1	4 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	Male	Control	not available	0	34	10	not available	Ctrl1	5 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Control	not available	0	22	11	not available	Ctrl2	6 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	1	Control
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	Female	Parkinson's disease with dementia	not available	2	24	26	not available	PDD2	7 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	1	Parkinson's disease with dementia
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Alzheimer's disease	not available	6	10	1	not available	AD1	8 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	4	24.5	2	not available	AD2	9 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	1	Alzheimer's disease
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD2	not available	INTSTD2	10 PXD006122-Sample-1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD3	not available	INTSTD3	1 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Parkinson's disease with dementia	not available	2	33	27	not available	PDD3	2 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Control	not available	2	48	12	not available	Ctrl3	3 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Dementia with Lewy bodies	not available	4	29	20	not available	DLB3	4 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Female	Parkinson's disease with dementia	not available	2	24	28	not available	PDD4	5 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Male	Dementia with Lewy bodies	not available	3	38	21	not available	DLB4	6 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	6	30	3	not available	AD3	7 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Male	Control	not available	0	21.5	13	not available	Ctrl4	8 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Alzheimer's disease	not available	6	14	4	not available	AD4	9 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD4	not available	INTSTD4	10 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD3	not available	INTSTD3	1 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Parkinson's disease with dementia	not available	2	33	27	not available	PDD3	2 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Control	not available	2	48	12	not available	Ctrl3	3 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Dementia with Lewy bodies	not available	4	29	20	not available	DLB3	4 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Female	Parkinson's disease with dementia	not available	2	24	28	not available	PDD4	5 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Male	Dementia with Lewy bodies	not available	3	38	21	not available	DLB4	6 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	6	30	3	not available	AD3	7 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Male	Control	not available	0	21.5	13	not available	Ctrl4	8 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Alzheimer's disease	not available	6	14	4	not available	AD4	9 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD4	not available	INTSTD4	10 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD3	not available	INTSTD3	1 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Parkinson's disease with dementia	not available	2	33	27	not available	PDD3	2 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Control	not available	2	48	12	not available	Ctrl3	3 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Dementia with Lewy bodies	not available	4	29	20	not available	DLB3	4 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Female	Parkinson's disease with dementia	not available	2	24	28	not available	PDD4	5 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Male	Dementia with Lewy bodies	not available	3	38	21	not available	DLB4	6 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	6	30	3	not available	AD3	7 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Male	Control	not available	0	21.5	13	not available	Ctrl4	8 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Alzheimer's disease	not available	6	14	4	not available	AD4	9 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD4	not available	INTSTD4	10 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD3	not available	INTSTD3	1 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Parkinson's disease with dementia	not available	2	33	27	not available	PDD3	2 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Control	not available	2	48	12	not available	Ctrl3	3 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Dementia with Lewy bodies	not available	4	29	20	not available	DLB3	4 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Female	Parkinson's disease with dementia	not available	2	24	28	not available	PDD4	5 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Male	Dementia with Lewy bodies	not available	3	38	21	not available	DLB4	6 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	6	30	3	not available	AD3	7 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Male	Control	not available	0	21.5	13	not available	Ctrl4	8 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Alzheimer's disease	not available	6	14	4	not available	AD4	9 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD4	not available	INTSTD4	10 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD3	not available	INTSTD3	1 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Parkinson's disease with dementia	not available	2	33	27	not available	PDD3	2 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Control	not available	2	48	12	not available	Ctrl3	3 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Dementia with Lewy bodies	not available	4	29	20	not available	DLB3	4 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Female	Parkinson's disease with dementia	not available	2	24	28	not available	PDD4	5 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Male	Dementia with Lewy bodies	not available	3	38	21	not available	DLB4	6 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	6	30	3	not available	AD3	7 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Male	Control	not available	0	21.5	13	not available	Ctrl4	8 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Alzheimer's disease	not available	6	14	4	not available	AD4	9 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD4	not available	INTSTD4	10 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD3	not available	INTSTD3	1 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Parkinson's disease with dementia	not available	2	33	27	not available	PDD3	2 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Control	not available	2	48	12	not available	Ctrl3	3 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Dementia with Lewy bodies	not available	4	29	20	not available	DLB3	4 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Female	Parkinson's disease with dementia	not available	2	24	28	not available	PDD4	5 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Male	Dementia with Lewy bodies	not available	3	38	21	not available	DLB4	6 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	6	30	3	not available	AD3	7 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Male	Control	not available	0	21.5	13	not available	Ctrl4	8 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Alzheimer's disease	not available	6	14	4	not available	AD4	9 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD4	not available	INTSTD4	10 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD3	not available	INTSTD3	1 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Parkinson's disease with dementia	not available	2	33	27	not available	PDD3	2 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Control	not available	2	48	12	not available	Ctrl3	3 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Dementia with Lewy bodies	not available	4	29	20	not available	DLB3	4 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Female	Parkinson's disease with dementia	not available	2	24	28	not available	PDD4	5 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Male	Dementia with Lewy bodies	not available	3	38	21	not available	DLB4	6 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	6	30	3	not available	AD3	7 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Male	Control	not available	0	21.5	13	not available	Ctrl4	8 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Alzheimer's disease	not available	6	14	4	not available	AD4	9 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD4	not available	INTSTD4	10 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD3	not available	INTSTD3	1 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Parkinson's disease with dementia	not available	2	33	27	not available	PDD3	2 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Control	not available	2	48	12	not available	Ctrl3	3 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Dementia with Lewy bodies	not available	4	29	20	not available	DLB3	4 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Female	Parkinson's disease with dementia	not available	2	24	28	not available	PDD4	5 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Male	Dementia with Lewy bodies	not available	3	38	21	not available	DLB4	6 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	6	30	3	not available	AD3	7 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Male	Control	not available	0	21.5	13	not available	Ctrl4	8 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Alzheimer's disease	not available	6	14	4	not available	AD4	9 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD4	not available	INTSTD4	10 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD3	not available	INTSTD3	1 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Parkinson's disease with dementia	not available	2	33	27	not available	PDD3	2 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Control	not available	2	48	12	not available	Ctrl3	3 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Dementia with Lewy bodies	not available	4	29	20	not available	DLB3	4 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Female	Parkinson's disease with dementia	not available	2	24	28	not available	PDD4	5 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Male	Dementia with Lewy bodies	not available	3	38	21	not available	DLB4	6 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	6	30	3	not available	AD3	7 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Male	Control	not available	0	21.5	13	not available	Ctrl4	8 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Alzheimer's disease	not available	6	14	4	not available	AD4	9 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD4	not available	INTSTD4	10 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD3	not available	INTSTD3	1 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Parkinson's disease with dementia	not available	2	33	27	not available	PDD3	2 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Control	not available	2	48	12	not available	Ctrl3	3 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Dementia with Lewy bodies	not available	4	29	20	not available	DLB3	4 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Female	Parkinson's disease with dementia	not available	2	24	28	not available	PDD4	5 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Male	Dementia with Lewy bodies	not available	3	38	21	not available	DLB4	6 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	6	30	3	not available	AD3	7 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Male	Control	not available	0	21.5	13	not available	Ctrl4	8 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Alzheimer's disease	not available	6	14	4	not available	AD4	9 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD4	not available	INTSTD4	10 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD3	not available	INTSTD3	1 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Parkinson's disease with dementia	not available	2	33	27	not available	PDD3	2 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Control	not available	2	48	12	not available	Ctrl3	3 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Dementia with Lewy bodies	not available	4	29	20	not available	DLB3	4 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Female	Parkinson's disease with dementia	not available	2	24	28	not available	PDD4	5 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Male	Dementia with Lewy bodies	not available	3	38	21	not available	DLB4	6 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	6	30	3	not available	AD3	7 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Male	Control	not available	0	21.5	13	not available	Ctrl4	8 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Alzheimer's disease	not available	6	14	4	not available	AD4	9 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD4	not available	INTSTD4	10 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD3	not available	INTSTD3	1 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Parkinson's disease with dementia	not available	2	33	27	not available	PDD3	2 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Control	not available	2	48	12	not available	Ctrl3	3 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Dementia with Lewy bodies	not available	4	29	20	not available	DLB3	4 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Female	Parkinson's disease with dementia	not available	2	24	28	not available	PDD4	5 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Male	Dementia with Lewy bodies	not available	3	38	21	not available	DLB4	6 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	6	30	3	not available	AD3	7 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Male	Control	not available	0	21.5	13	not available	Ctrl4	8 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Alzheimer's disease	not available	6	14	4	not available	AD4	9 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD4	not available	INTSTD4	10 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD3	not available	INTSTD3	1 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Parkinson's disease with dementia	not available	2	33	27	not available	PDD3	2 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Control	not available	2	48	12	not available	Ctrl3	3 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Dementia with Lewy bodies	not available	4	29	20	not available	DLB3	4 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Female	Parkinson's disease with dementia	not available	2	24	28	not available	PDD4	5 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Male	Dementia with Lewy bodies	not available	3	38	21	not available	DLB4	6 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	6	30	3	not available	AD3	7 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Male	Control	not available	0	21.5	13	not available	Ctrl4	8 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Alzheimer's disease	not available	6	14	4	not available	AD4	9 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD4	not available	INTSTD4	10 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD3	not available	INTSTD3	1 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Parkinson's disease with dementia	not available	2	33	27	not available	PDD3	2 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Control	not available	2	48	12	not available	Ctrl3	3 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Dementia with Lewy bodies	not available	4	29	20	not available	DLB3	4 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Female	Parkinson's disease with dementia	not available	2	24	28	not available	PDD4	5 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Male	Dementia with Lewy bodies	not available	3	38	21	not available	DLB4	6 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	6	30	3	not available	AD3	7 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Male	Control	not available	0	21.5	13	not available	Ctrl4	8 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Alzheimer's disease	not available	6	14	4	not available	AD4	9 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD4	not available	INTSTD4	10 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD3	not available	INTSTD3	1 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Parkinson's disease with dementia	not available	2	33	27	not available	PDD3	2 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Control	not available	2	48	12	not available	Ctrl3	3 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Dementia with Lewy bodies	not available	4	29	20	not available	DLB3	4 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Female	Parkinson's disease with dementia	not available	2	24	28	not available	PDD4	5 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Male	Dementia with Lewy bodies	not available	3	38	21	not available	DLB4	6 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	6	30	3	not available	AD3	7 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Male	Control	not available	0	21.5	13	not available	Ctrl4	8 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Alzheimer's disease	not available	6	14	4	not available	AD4	9 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD4	not available	INTSTD4	10 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD3	not available	INTSTD3	1 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Parkinson's disease with dementia	not available	2	33	27	not available	PDD3	2 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Control	not available	2	48	12	not available	Ctrl3	3 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Dementia with Lewy bodies	not available	4	29	20	not available	DLB3	4 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Female	Parkinson's disease with dementia	not available	2	24	28	not available	PDD4	5 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Male	Dementia with Lewy bodies	not available	3	38	21	not available	DLB4	6 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	6	30	3	not available	AD3	7 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Male	Control	not available	0	21.5	13	not available	Ctrl4	8 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Alzheimer's disease	not available	6	14	4	not available	AD4	9 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD4	not available	INTSTD4	10 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD3	not available	INTSTD3	1 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Parkinson's disease with dementia	not available	2	33	27	not available	PDD3	2 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Control	not available	2	48	12	not available	Ctrl3	3 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Dementia with Lewy bodies	not available	4	29	20	not available	DLB3	4 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Female	Parkinson's disease with dementia	not available	2	24	28	not available	PDD4	5 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Male	Dementia with Lewy bodies	not available	3	38	21	not available	DLB4	6 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	6	30	3	not available	AD3	7 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Male	Control	not available	0	21.5	13	not available	Ctrl4	8 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Alzheimer's disease	not available	6	14	4	not available	AD4	9 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD4	not available	INTSTD4	10 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD3	not available	INTSTD3	1 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Parkinson's disease with dementia	not available	2	33	27	not available	PDD3	2 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Control	not available	2	48	12	not available	Ctrl3	3 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Dementia with Lewy bodies	not available	4	29	20	not available	DLB3	4 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Female	Parkinson's disease with dementia	not available	2	24	28	not available	PDD4	5 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Male	Dementia with Lewy bodies	not available	3	38	21	not available	DLB4	6 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	6	30	3	not available	AD3	7 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Male	Control	not available	0	21.5	13	not available	Ctrl4	8 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Alzheimer's disease	not available	6	14	4	not available	AD4	9 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD4	not available	INTSTD4	10 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD3	not available	INTSTD3	1 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Parkinson's disease with dementia	not available	2	33	27	not available	PDD3	2 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Control	not available	2	48	12	not available	Ctrl3	3 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Dementia with Lewy bodies	not available	4	29	20	not available	DLB3	4 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Female	Parkinson's disease with dementia	not available	2	24	28	not available	PDD4	5 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Male	Dementia with Lewy bodies	not available	3	38	21	not available	DLB4	6 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	6	30	3	not available	AD3	7 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Male	Control	not available	0	21.5	13	not available	Ctrl4	8 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Alzheimer's disease	not available	6	14	4	not available	AD4	9 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD4	not available	INTSTD4	10 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD3	not available	INTSTD3	1 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Parkinson's disease with dementia	not available	2	33	27	not available	PDD3	2 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Control	not available	2	48	12	not available	Ctrl3	3 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Dementia with Lewy bodies	not available	4	29	20	not available	DLB3	4 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Female	Parkinson's disease with dementia	not available	2	24	28	not available	PDD4	5 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Male	Dementia with Lewy bodies	not available	3	38	21	not available	DLB4	6 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	6	30	3	not available	AD3	7 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Male	Control	not available	0	21.5	13	not available	Ctrl4	8 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Alzheimer's disease	not available	6	14	4	not available	AD4	9 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD4	not available	INTSTD4	10 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD3	not available	INTSTD3	1 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Parkinson's disease with dementia	not available	2	33	27	not available	PDD3	2 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Control	not available	2	48	12	not available	Ctrl3	3 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Dementia with Lewy bodies	not available	4	29	20	not available	DLB3	4 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Female	Parkinson's disease with dementia	not available	2	24	28	not available	PDD4	5 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Male	Dementia with Lewy bodies	not available	3	38	21	not available	DLB4	6 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	6	30	3	not available	AD3	7 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Male	Control	not available	0	21.5	13	not available	Ctrl4	8 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Alzheimer's disease	not available	6	14	4	not available	AD4	9 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD4	not available	INTSTD4	10 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD3	not available	INTSTD3	1 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Parkinson's disease with dementia	not available	2	33	27	not available	PDD3	2 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Control	not available	2	48	12	not available	Ctrl3	3 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Dementia with Lewy bodies	not available	4	29	20	not available	DLB3	4 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Female	Parkinson's disease with dementia	not available	2	24	28	not available	PDD4	5 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Male	Dementia with Lewy bodies	not available	3	38	21	not available	DLB4	6 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	6	30	3	not available	AD3	7 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Male	Control	not available	0	21.5	13	not available	Ctrl4	8 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Alzheimer's disease	not available	6	14	4	not available	AD4	9 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD4	not available	INTSTD4	10 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD3	not available	INTSTD3	1 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Parkinson's disease with dementia	not available	2	33	27	not available	PDD3	2 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Control	not available	2	48	12	not available	Ctrl3	3 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Dementia with Lewy bodies	not available	4	29	20	not available	DLB3	4 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Female	Parkinson's disease with dementia	not available	2	24	28	not available	PDD4	5 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Male	Dementia with Lewy bodies	not available	3	38	21	not available	DLB4	6 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	6	30	3	not available	AD3	7 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Male	Control	not available	0	21.5	13	not available	Ctrl4	8 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Alzheimer's disease	not available	6	14	4	not available	AD4	9 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD4	not available	INTSTD4	10 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD3	not available	INTSTD3	1 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Parkinson's disease with dementia	not available	2	33	27	not available	PDD3	2 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Control	not available	2	48	12	not available	Ctrl3	3 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Dementia with Lewy bodies	not available	4	29	20	not available	DLB3	4 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Female	Parkinson's disease with dementia	not available	2	24	28	not available	PDD4	5 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Male	Dementia with Lewy bodies	not available	3	38	21	not available	DLB4	6 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	6	30	3	not available	AD3	7 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Male	Control	not available	0	21.5	13	not available	Ctrl4	8 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Alzheimer's disease	not available	6	14	4	not available	AD4	9 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD4	not available	INTSTD4	10 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD3	not available	INTSTD3	1 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Parkinson's disease with dementia	not available	2	33	27	not available	PDD3	2 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Control	not available	2	48	12	not available	Ctrl3	3 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Dementia with Lewy bodies	not available	4	29	20	not available	DLB3	4 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Female	Parkinson's disease with dementia	not available	2	24	28	not available	PDD4	5 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Male	Dementia with Lewy bodies	not available	3	38	21	not available	DLB4	6 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	6	30	3	not available	AD3	7 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Male	Control	not available	0	21.5	13	not available	Ctrl4	8 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Alzheimer's disease	not available	6	14	4	not available	AD4	9 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD4	not available	INTSTD4	10 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD3	not available	INTSTD3	1 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Parkinson's disease with dementia	not available	2	33	27	not available	PDD3	2 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Control	not available	2	48	12	not available	Ctrl3	3 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Dementia with Lewy bodies	not available	4	29	20	not available	DLB3	4 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Female	Parkinson's disease with dementia	not available	2	24	28	not available	PDD4	5 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Male	Dementia with Lewy bodies	not available	3	38	21	not available	DLB4	6 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	6	30	3	not available	AD3	7 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Male	Control	not available	0	21.5	13	not available	Ctrl4	8 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Alzheimer's disease	not available	6	14	4	not available	AD4	9 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD4	not available	INTSTD4	10 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD3	not available	INTSTD3	1 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Parkinson's disease with dementia	not available	2	33	27	not available	PDD3	2 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Control	not available	2	48	12	not available	Ctrl3	3 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Dementia with Lewy bodies	not available	4	29	20	not available	DLB3	4 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Female	Parkinson's disease with dementia	not available	2	24	28	not available	PDD4	5 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Male	Dementia with Lewy bodies	not available	3	38	21	not available	DLB4	6 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	6	30	3	not available	AD3	7 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Male	Control	not available	0	21.5	13	not available	Ctrl4	8 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Alzheimer's disease	not available	6	14	4	not available	AD4	9 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD4	not available	INTSTD4	10 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD3	not available	INTSTD3	1 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Parkinson's disease with dementia	not available	2	33	27	not available	PDD3	2 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Control	not available	2	48	12	not available	Ctrl3	3 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Dementia with Lewy bodies	not available	4	29	20	not available	DLB3	4 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Female	Parkinson's disease with dementia	not available	2	24	28	not available	PDD4	5 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Male	Dementia with Lewy bodies	not available	3	38	21	not available	DLB4	6 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	6	30	3	not available	AD3	7 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Male	Control	not available	0	21.5	13	not available	Ctrl4	8 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Alzheimer's disease	not available	6	14	4	not available	AD4	9 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD4	not available	INTSTD4	10 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD3	not available	INTSTD3	1 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Parkinson's disease with dementia	not available	2	33	27	not available	PDD3	2 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Control	not available	2	48	12	not available	Ctrl3	3 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Dementia with Lewy bodies	not available	4	29	20	not available	DLB3	4 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Female	Parkinson's disease with dementia	not available	2	24	28	not available	PDD4	5 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Male	Dementia with Lewy bodies	not available	3	38	21	not available	DLB4	6 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	6	30	3	not available	AD3	7 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Male	Control	not available	0	21.5	13	not available	Ctrl4	8 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Alzheimer's disease	not available	6	14	4	not available	AD4	9 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD4	not available	INTSTD4	10 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD3	not available	INTSTD3	1 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Parkinson's disease with dementia	not available	2	33	27	not available	PDD3	2 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Control	not available	2	48	12	not available	Ctrl3	3 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Dementia with Lewy bodies	not available	4	29	20	not available	DLB3	4 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Female	Parkinson's disease with dementia	not available	2	24	28	not available	PDD4	5 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Male	Dementia with Lewy bodies	not available	3	38	21	not available	DLB4	6 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	6	30	3	not available	AD3	7 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Male	Control	not available	0	21.5	13	not available	Ctrl4	8 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Alzheimer's disease	not available	6	14	4	not available	AD4	9 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD4	not available	INTSTD4	10 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD3	not available	INTSTD3	1 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Parkinson's disease with dementia	not available	2	33	27	not available	PDD3	2 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Control	not available	2	48	12	not available	Ctrl3	3 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Dementia with Lewy bodies	not available	4	29	20	not available	DLB3	4 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Female	Parkinson's disease with dementia	not available	2	24	28	not available	PDD4	5 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Male	Dementia with Lewy bodies	not available	3	38	21	not available	DLB4	6 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	6	30	3	not available	AD3	7 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Male	Control	not available	0	21.5	13	not available	Ctrl4	8 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Alzheimer's disease	not available	6	14	4	not available	AD4	9 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD4	not available	INTSTD4	10 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD3	not available	INTSTD3	1 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Parkinson's disease with dementia	not available	2	33	27	not available	PDD3	2 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Control	not available	2	48	12	not available	Ctrl3	3 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Dementia with Lewy bodies	not available	4	29	20	not available	DLB3	4 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Female	Parkinson's disease with dementia	not available	2	24	28	not available	PDD4	5 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Male	Dementia with Lewy bodies	not available	3	38	21	not available	DLB4	6 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	6	30	3	not available	AD3	7 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Male	Control	not available	0	21.5	13	not available	Ctrl4	8 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Alzheimer's disease	not available	6	14	4	not available	AD4	9 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD4	not available	INTSTD4	10 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD3	not available	INTSTD3	1 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Parkinson's disease with dementia	not available	2	33	27	not available	PDD3	2 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Control	not available	2	48	12	not available	Ctrl3	3 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Dementia with Lewy bodies	not available	4	29	20	not available	DLB3	4 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Female	Parkinson's disease with dementia	not available	2	24	28	not available	PDD4	5 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Male	Dementia with Lewy bodies	not available	3	38	21	not available	DLB4	6 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	6	30	3	not available	AD3	7 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Male	Control	not available	0	21.5	13	not available	Ctrl4	8 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Alzheimer's disease	not available	6	14	4	not available	AD4	9 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD4	not available	INTSTD4	10 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD3	not available	INTSTD3	1 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Parkinson's disease with dementia	not available	2	33	27	not available	PDD3	2 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Control	not available	2	48	12	not available	Ctrl3	3 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Dementia with Lewy bodies	not available	4	29	20	not available	DLB3	4 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Female	Parkinson's disease with dementia	not available	2	24	28	not available	PDD4	5 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Male	Dementia with Lewy bodies	not available	3	38	21	not available	DLB4	6 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	6	30	3	not available	AD3	7 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Male	Control	not available	0	21.5	13	not available	Ctrl4	8 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Alzheimer's disease	not available	6	14	4	not available	AD4	9 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD4	not available	INTSTD4	10 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD3	not available	INTSTD3	1 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Parkinson's disease with dementia	not available	2	33	27	not available	PDD3	2 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Control	not available	2	48	12	not available	Ctrl3	3 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Dementia with Lewy bodies	not available	4	29	20	not available	DLB3	4 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Female	Parkinson's disease with dementia	not available	2	24	28	not available	PDD4	5 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Male	Dementia with Lewy bodies	not available	3	38	21	not available	DLB4	6 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	6	30	3	not available	AD3	7 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Male	Control	not available	0	21.5	13	not available	Ctrl4	8 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Alzheimer's disease	not available	6	14	4	not available	AD4	9 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD4	not available	INTSTD4	10 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD3	not available	INTSTD3	1 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Parkinson's disease with dementia	not available	2	33	27	not available	PDD3	2 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Control	not available	2	48	12	not available	Ctrl3	3 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Dementia with Lewy bodies	not available	4	29	20	not available	DLB3	4 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Female	Parkinson's disease with dementia	not available	2	24	28	not available	PDD4	5 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Male	Dementia with Lewy bodies	not available	3	38	21	not available	DLB4	6 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	6	30	3	not available	AD3	7 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Male	Control	not available	0	21.5	13	not available	Ctrl4	8 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Alzheimer's disease	not available	6	14	4	not available	AD4	9 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD4	not available	INTSTD4	10 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD3	not available	INTSTD3	1 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Parkinson's disease with dementia	not available	2	33	27	not available	PDD3	2 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Control	not available	2	48	12	not available	Ctrl3	3 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Dementia with Lewy bodies	not available	4	29	20	not available	DLB3	4 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Female	Parkinson's disease with dementia	not available	2	24	28	not available	PDD4	5 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Male	Dementia with Lewy bodies	not available	3	38	21	not available	DLB4	6 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	6	30	3	not available	AD3	7 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Male	Control	not available	0	21.5	13	not available	Ctrl4	8 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Alzheimer's disease	not available	6	14	4	not available	AD4	9 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD4	not available	INTSTD4	10 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD3	not available	INTSTD3	1 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Parkinson's disease with dementia	not available	2	33	27	not available	PDD3	2 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Control	not available	2	48	12	not available	Ctrl3	3 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Dementia with Lewy bodies	not available	4	29	20	not available	DLB3	4 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Female	Parkinson's disease with dementia	not available	2	24	28	not available	PDD4	5 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Male	Dementia with Lewy bodies	not available	3	38	21	not available	DLB4	6 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	6	30	3	not available	AD3	7 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Male	Control	not available	0	21.5	13	not available	Ctrl4	8 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Alzheimer's disease	not available	6	14	4	not available	AD4	9 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD4	not available	INTSTD4	10 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD3	not available	INTSTD3	1 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Parkinson's disease with dementia	not available	2	33	27	not available	PDD3	2 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Control	not available	2	48	12	not available	Ctrl3	3 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Dementia with Lewy bodies	not available	4	29	20	not available	DLB3	4 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Female	Parkinson's disease with dementia	not available	2	24	28	not available	PDD4	5 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Male	Dementia with Lewy bodies	not available	3	38	21	not available	DLB4	6 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	6	30	3	not available	AD3	7 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Male	Control	not available	0	21.5	13	not available	Ctrl4	8 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Alzheimer's disease	not available	6	14	4	not available	AD4	9 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD4	not available	INTSTD4	10 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD3	not available	INTSTD3	1 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Parkinson's disease with dementia	not available	2	33	27	not available	PDD3	2 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Control	not available	2	48	12	not available	Ctrl3	3 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Dementia with Lewy bodies	not available	4	29	20	not available	DLB3	4 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Female	Parkinson's disease with dementia	not available	2	24	28	not available	PDD4	5 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Male	Dementia with Lewy bodies	not available	3	38	21	not available	DLB4	6 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	6	30	3	not available	AD3	7 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Male	Control	not available	0	21.5	13	not available	Ctrl4	8 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Alzheimer's disease	not available	6	14	4	not available	AD4	9 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD4	not available	INTSTD4	10 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD3	not available	INTSTD3	1 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Parkinson's disease with dementia	not available	2	33	27	not available	PDD3	2 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Control	not available	2	48	12	not available	Ctrl3	3 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Dementia with Lewy bodies	not available	4	29	20	not available	DLB3	4 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Female	Parkinson's disease with dementia	not available	2	24	28	not available	PDD4	5 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Male	Dementia with Lewy bodies	not available	3	38	21	not available	DLB4	6 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	6	30	3	not available	AD3	7 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Male	Control	not available	0	21.5	13	not available	Ctrl4	8 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Alzheimer's disease	not available	6	14	4	not available	AD4	9 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD4	not available	INTSTD4	10 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD3	not available	INTSTD3	1 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Parkinson's disease with dementia	not available	2	33	27	not available	PDD3	2 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Control	not available	2	48	12	not available	Ctrl3	3 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Dementia with Lewy bodies	not available	4	29	20	not available	DLB3	4 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Female	Parkinson's disease with dementia	not available	2	24	28	not available	PDD4	5 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Male	Dementia with Lewy bodies	not available	3	38	21	not available	DLB4	6 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	6	30	3	not available	AD3	7 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Male	Control	not available	0	21.5	13	not available	Ctrl4	8 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Alzheimer's disease	not available	6	14	4	not available	AD4	9 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD4	not available	INTSTD4	10 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD3	not available	INTSTD3	1 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Parkinson's disease with dementia	not available	2	33	27	not available	PDD3	2 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Control	not available	2	48	12	not available	Ctrl3	3 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Dementia with Lewy bodies	not available	4	29	20	not available	DLB3	4 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Female	Parkinson's disease with dementia	not available	2	24	28	not available	PDD4	5 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Male	Dementia with Lewy bodies	not available	3	38	21	not available	DLB4	6 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	6	30	3	not available	AD3	7 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Male	Control	not available	0	21.5	13	not available	Ctrl4	8 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Alzheimer's disease	not available	6	14	4	not available	AD4	9 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD4	not available	INTSTD4	10 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD3	not available	INTSTD3	1 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Parkinson's disease with dementia	not available	2	33	27	not available	PDD3	2 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Control	not available	2	48	12	not available	Ctrl3	3 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Dementia with Lewy bodies	not available	4	29	20	not available	DLB3	4 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Female	Parkinson's disease with dementia	not available	2	24	28	not available	PDD4	5 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Male	Dementia with Lewy bodies	not available	3	38	21	not available	DLB4	6 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	6	30	3	not available	AD3	7 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Male	Control	not available	0	21.5	13	not available	Ctrl4	8 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Alzheimer's disease	not available	6	14	4	not available	AD4	9 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD4	not available	INTSTD4	10 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD3	not available	INTSTD3	1 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Parkinson's disease with dementia	not available	2	33	27	not available	PDD3	2 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Control	not available	2	48	12	not available	Ctrl3	3 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Dementia with Lewy bodies	not available	4	29	20	not available	DLB3	4 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Female	Parkinson's disease with dementia	not available	2	24	28	not available	PDD4	5 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Male	Dementia with Lewy bodies	not available	3	38	21	not available	DLB4	6 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	6	30	3	not available	AD3	7 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Male	Control	not available	0	21.5	13	not available	Ctrl4	8 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Alzheimer's disease	not available	6	14	4	not available	AD4	9 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD4	not available	INTSTD4	10 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD3	not available	INTSTD3	1 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Parkinson's disease with dementia	not available	2	33	27	not available	PDD3	2 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Control	not available	2	48	12	not available	Ctrl3	3 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Dementia with Lewy bodies	not available	4	29	20	not available	DLB3	4 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Female	Parkinson's disease with dementia	not available	2	24	28	not available	PDD4	5 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Male	Dementia with Lewy bodies	not available	3	38	21	not available	DLB4	6 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	6	30	3	not available	AD3	7 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Male	Control	not available	0	21.5	13	not available	Ctrl4	8 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Alzheimer's disease	not available	6	14	4	not available	AD4	9 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD4	not available	INTSTD4	10 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD3	not available	INTSTD3	1 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Parkinson's disease with dementia	not available	2	33	27	not available	PDD3	2 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Control	not available	2	48	12	not available	Ctrl3	3 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Dementia with Lewy bodies	not available	4	29	20	not available	DLB3	4 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Female	Parkinson's disease with dementia	not available	2	24	28	not available	PDD4	5 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Male	Dementia with Lewy bodies	not available	3	38	21	not available	DLB4	6 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	6	30	3	not available	AD3	7 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Male	Control	not available	0	21.5	13	not available	Ctrl4	8 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Alzheimer's disease	not available	6	14	4	not available	AD4	9 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD4	not available	INTSTD4	10 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD3	not available	INTSTD3	1 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Parkinson's disease with dementia	not available	2	33	27	not available	PDD3	2 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Control	not available	2	48	12	not available	Ctrl3	3 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Dementia with Lewy bodies	not available	4	29	20	not available	DLB3	4 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Female	Parkinson's disease with dementia	not available	2	24	28	not available	PDD4	5 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Male	Dementia with Lewy bodies	not available	3	38	21	not available	DLB4	6 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	6	30	3	not available	AD3	7 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Male	Control	not available	0	21.5	13	not available	Ctrl4	8 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Alzheimer's disease	not available	6	14	4	not available	AD4	9 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD4	not available	INTSTD4	10 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD3	not available	INTSTD3	1 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Parkinson's disease with dementia	not available	2	33	27	not available	PDD3	2 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Control	not available	2	48	12	not available	Ctrl3	3 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Dementia with Lewy bodies	not available	4	29	20	not available	DLB3	4 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Female	Parkinson's disease with dementia	not available	2	24	28	not available	PDD4	5 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Male	Dementia with Lewy bodies	not available	3	38	21	not available	DLB4	6 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	6	30	3	not available	AD3	7 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Male	Control	not available	0	21.5	13	not available	Ctrl4	8 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Alzheimer's disease	not available	6	14	4	not available	AD4	9 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD4	not available	INTSTD4	10 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD3	not available	INTSTD3	1 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Parkinson's disease with dementia	not available	2	33	27	not available	PDD3	2 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Control	not available	2	48	12	not available	Ctrl3	3 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Dementia with Lewy bodies	not available	4	29	20	not available	DLB3	4 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Female	Parkinson's disease with dementia	not available	2	24	28	not available	PDD4	5 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Male	Dementia with Lewy bodies	not available	3	38	21	not available	DLB4	6 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	6	30	3	not available	AD3	7 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Male	Control	not available	0	21.5	13	not available	Ctrl4	8 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Alzheimer's disease	not available	6	14	4	not available	AD4	9 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD4	not available	INTSTD4	10 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD3	not available	INTSTD3	1 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Parkinson's disease with dementia	not available	2	33	27	not available	PDD3	2 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Control	not available	2	48	12	not available	Ctrl3	3 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Dementia with Lewy bodies	not available	4	29	20	not available	DLB3	4 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Female	Parkinson's disease with dementia	not available	2	24	28	not available	PDD4	5 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Male	Dementia with Lewy bodies	not available	3	38	21	not available	DLB4	6 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	6	30	3	not available	AD3	7 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Male	Control	not available	0	21.5	13	not available	Ctrl4	8 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Alzheimer's disease	not available	6	14	4	not available	AD4	9 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD4	not available	INTSTD4	10 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD3	not available	INTSTD3	1 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Parkinson's disease with dementia	not available	2	33	27	not available	PDD3	2 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Control	not available	2	48	12	not available	Ctrl3	3 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Dementia with Lewy bodies	not available	4	29	20	not available	DLB3	4 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Female	Parkinson's disease with dementia	not available	2	24	28	not available	PDD4	5 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Male	Dementia with Lewy bodies	not available	3	38	21	not available	DLB4	6 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	6	30	3	not available	AD3	7 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Male	Control	not available	0	21.5	13	not available	Ctrl4	8 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Alzheimer's disease	not available	6	14	4	not available	AD4	9 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD4	not available	INTSTD4	10 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD3	not available	INTSTD3	1 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Parkinson's disease with dementia	not available	2	33	27	not available	PDD3	2 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Control	not available	2	48	12	not available	Ctrl3	3 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Dementia with Lewy bodies	not available	4	29	20	not available	DLB3	4 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Female	Parkinson's disease with dementia	not available	2	24	28	not available	PDD4	5 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Male	Dementia with Lewy bodies	not available	3	38	21	not available	DLB4	6 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	6	30	3	not available	AD3	7 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Male	Control	not available	0	21.5	13	not available	Ctrl4	8 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Alzheimer's disease	not available	6	14	4	not available	AD4	9 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD4	not available	INTSTD4	10 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD3	not available	INTSTD3	1 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Parkinson's disease with dementia	not available	2	33	27	not available	PDD3	2 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Control	not available	2	48	12	not available	Ctrl3	3 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Dementia with Lewy bodies	not available	4	29	20	not available	DLB3	4 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Female	Parkinson's disease with dementia	not available	2	24	28	not available	PDD4	5 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Male	Dementia with Lewy bodies	not available	3	38	21	not available	DLB4	6 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	6	30	3	not available	AD3	7 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Male	Control	not available	0	21.5	13	not available	Ctrl4	8 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Alzheimer's disease	not available	6	14	4	not available	AD4	9 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD4	not available	INTSTD4	10 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD3	not available	INTSTD3	1 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Parkinson's disease with dementia	not available	2	33	27	not available	PDD3	2 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Control	not available	2	48	12	not available	Ctrl3	3 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Dementia with Lewy bodies	not available	4	29	20	not available	DLB3	4 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Female	Parkinson's disease with dementia	not available	2	24	28	not available	PDD4	5 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Male	Dementia with Lewy bodies	not available	3	38	21	not available	DLB4	6 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	6	30	3	not available	AD3	7 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Male	Control	not available	0	21.5	13	not available	Ctrl4	8 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Alzheimer's disease	not available	6	14	4	not available	AD4	9 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD4	not available	INTSTD4	10 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD3	not available	INTSTD3	1 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Parkinson's disease with dementia	not available	2	33	27	not available	PDD3	2 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Control	not available	2	48	12	not available	Ctrl3	3 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Dementia with Lewy bodies	not available	4	29	20	not available	DLB3	4 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Female	Parkinson's disease with dementia	not available	2	24	28	not available	PDD4	5 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Male	Dementia with Lewy bodies	not available	3	38	21	not available	DLB4	6 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	6	30	3	not available	AD3	7 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Male	Control	not available	0	21.5	13	not available	Ctrl4	8 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Alzheimer's disease	not available	6	14	4	not available	AD4	9 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD4	not available	INTSTD4	10 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD3	not available	INTSTD3	1 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Parkinson's disease with dementia	not available	2	33	27	not available	PDD3	2 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Control	not available	2	48	12	not available	Ctrl3	3 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Dementia with Lewy bodies	not available	4	29	20	not available	DLB3	4 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Female	Parkinson's disease with dementia	not available	2	24	28	not available	PDD4	5 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Male	Dementia with Lewy bodies	not available	3	38	21	not available	DLB4	6 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	6	30	3	not available	AD3	7 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Male	Control	not available	0	21.5	13	not available	Ctrl4	8 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Alzheimer's disease	not available	6	14	4	not available	AD4	9 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD4	not available	INTSTD4	10 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD3	not available	INTSTD3	1 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Parkinson's disease with dementia	not available	2	33	27	not available	PDD3	2 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Control	not available	2	48	12	not available	Ctrl3	3 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Dementia with Lewy bodies	not available	4	29	20	not available	DLB3	4 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Female	Parkinson's disease with dementia	not available	2	24	28	not available	PDD4	5 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Male	Dementia with Lewy bodies	not available	3	38	21	not available	DLB4	6 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	6	30	3	not available	AD3	7 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Male	Control	not available	0	21.5	13	not available	Ctrl4	8 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Alzheimer's disease	not available	6	14	4	not available	AD4	9 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD4	not available	INTSTD4	10 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD3	not available	INTSTD3	1 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Parkinson's disease with dementia	not available	2	33	27	not available	PDD3	2 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Control	not available	2	48	12	not available	Ctrl3	3 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Dementia with Lewy bodies	not available	4	29	20	not available	DLB3	4 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Female	Parkinson's disease with dementia	not available	2	24	28	not available	PDD4	5 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Male	Dementia with Lewy bodies	not available	3	38	21	not available	DLB4	6 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	6	30	3	not available	AD3	7 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Male	Control	not available	0	21.5	13	not available	Ctrl4	8 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Alzheimer's disease	not available	6	14	4	not available	AD4	9 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD4	not available	INTSTD4	10 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD3	not available	INTSTD3	1 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Parkinson's disease with dementia	not available	2	33	27	not available	PDD3	2 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Control	not available	2	48	12	not available	Ctrl3	3 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Dementia with Lewy bodies	not available	4	29	20	not available	DLB3	4 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Female	Parkinson's disease with dementia	not available	2	24	28	not available	PDD4	5 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Male	Dementia with Lewy bodies	not available	3	38	21	not available	DLB4	6 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	6	30	3	not available	AD3	7 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Male	Control	not available	0	21.5	13	not available	Ctrl4	8 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Alzheimer's disease	not available	6	14	4	not available	AD4	9 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD4	not available	INTSTD4	10 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD3	not available	INTSTD3	1 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Parkinson's disease with dementia	not available	2	33	27	not available	PDD3	2 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Control	not available	2	48	12	not available	Ctrl3	3 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Dementia with Lewy bodies	not available	4	29	20	not available	DLB3	4 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Female	Parkinson's disease with dementia	not available	2	24	28	not available	PDD4	5 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Male	Dementia with Lewy bodies	not available	3	38	21	not available	DLB4	6 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	6	30	3	not available	AD3	7 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Male	Control	not available	0	21.5	13	not available	Ctrl4	8 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Alzheimer's disease	not available	6	14	4	not available	AD4	9 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD4	not available	INTSTD4	10 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD3	not available	INTSTD3	1 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Parkinson's disease with dementia	not available	2	33	27	not available	PDD3	2 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Control	not available	2	48	12	not available	Ctrl3	3 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Dementia with Lewy bodies	not available	4	29	20	not available	DLB3	4 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Female	Parkinson's disease with dementia	not available	2	24	28	not available	PDD4	5 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Male	Dementia with Lewy bodies	not available	3	38	21	not available	DLB4	6 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	6	30	3	not available	AD3	7 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Male	Control	not available	0	21.5	13	not available	Ctrl4	8 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Alzheimer's disease	not available	6	14	4	not available	AD4	9 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD4	not available	INTSTD4	10 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD3	not available	INTSTD3	1 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Parkinson's disease with dementia	not available	2	33	27	not available	PDD3	2 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Control	not available	2	48	12	not available	Ctrl3	3 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Dementia with Lewy bodies	not available	4	29	20	not available	DLB3	4 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Female	Parkinson's disease with dementia	not available	2	24	28	not available	PDD4	5 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Male	Dementia with Lewy bodies	not available	3	38	21	not available	DLB4	6 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	6	30	3	not available	AD3	7 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Male	Control	not available	0	21.5	13	not available	Ctrl4	8 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Alzheimer's disease	not available	6	14	4	not available	AD4	9 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD4	not available	INTSTD4	10 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD3	not available	INTSTD3	1 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Parkinson's disease with dementia	not available	2	33	27	not available	PDD3	2 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Control	not available	2	48	12	not available	Ctrl3	3 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Dementia with Lewy bodies	not available	4	29	20	not available	DLB3	4 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Female	Parkinson's disease with dementia	not available	2	24	28	not available	PDD4	5 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Male	Dementia with Lewy bodies	not available	3	38	21	not available	DLB4	6 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	6	30	3	not available	AD3	7 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Male	Control	not available	0	21.5	13	not available	Ctrl4	8 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Alzheimer's disease	not available	6	14	4	not available	AD4	9 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD4	not available	INTSTD4	10 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD3	not available	INTSTD3	1 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Parkinson's disease with dementia	not available	2	33	27	not available	PDD3	2 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Control	not available	2	48	12	not available	Ctrl3	3 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Dementia with Lewy bodies	not available	4	29	20	not available	DLB3	4 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Female	Parkinson's disease with dementia	not available	2	24	28	not available	PDD4	5 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Male	Dementia with Lewy bodies	not available	3	38	21	not available	DLB4	6 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	6	30	3	not available	AD3	7 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Male	Control	not available	0	21.5	13	not available	Ctrl4	8 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Alzheimer's disease	not available	6	14	4	not available	AD4	9 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD4	not available	INTSTD4	10 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD3	not available	INTSTD3	1 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Parkinson's disease with dementia	not available	2	33	27	not available	PDD3	2 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Control	not available	2	48	12	not available	Ctrl3	3 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Dementia with Lewy bodies	not available	4	29	20	not available	DLB3	4 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Female	Parkinson's disease with dementia	not available	2	24	28	not available	PDD4	5 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Male	Dementia with Lewy bodies	not available	3	38	21	not available	DLB4	6 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	6	30	3	not available	AD3	7 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Male	Control	not available	0	21.5	13	not available	Ctrl4	8 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Alzheimer's disease	not available	6	14	4	not available	AD4	9 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD4	not available	INTSTD4	10 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD3	not available	INTSTD3	1 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Parkinson's disease with dementia	not available	2	33	27	not available	PDD3	2 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Control	not available	2	48	12	not available	Ctrl3	3 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Dementia with Lewy bodies	not available	4	29	20	not available	DLB3	4 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Female	Parkinson's disease with dementia	not available	2	24	28	not available	PDD4	5 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Male	Dementia with Lewy bodies	not available	3	38	21	not available	DLB4	6 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	6	30	3	not available	AD3	7 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Male	Control	not available	0	21.5	13	not available	Ctrl4	8 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Alzheimer's disease	not available	6	14	4	not available	AD4	9 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD4	not available	INTSTD4	10 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD3	not available	INTSTD3	1 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Parkinson's disease with dementia	not available	2	33	27	not available	PDD3	2 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Control	not available	2	48	12	not available	Ctrl3	3 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Dementia with Lewy bodies	not available	4	29	20	not available	DLB3	4 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Female	Parkinson's disease with dementia	not available	2	24	28	not available	PDD4	5 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Male	Dementia with Lewy bodies	not available	3	38	21	not available	DLB4	6 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	6	30	3	not available	AD3	7 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Male	Control	not available	0	21.5	13	not available	Ctrl4	8 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Alzheimer's disease	not available	6	14	4	not available	AD4	9 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD4	not available	INTSTD4	10 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD3	not available	INTSTD3	1 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Parkinson's disease with dementia	not available	2	33	27	not available	PDD3	2 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Control	not available	2	48	12	not available	Ctrl3	3 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Dementia with Lewy bodies	not available	4	29	20	not available	DLB3	4 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Female	Parkinson's disease with dementia	not available	2	24	28	not available	PDD4	5 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Male	Dementia with Lewy bodies	not available	3	38	21	not available	DLB4	6 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	6	30	3	not available	AD3	7 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Male	Control	not available	0	21.5	13	not available	Ctrl4	8 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Alzheimer's disease	not available	6	14	4	not available	AD4	9 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD4	not available	INTSTD4	10 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD3	not available	INTSTD3	1 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Parkinson's disease with dementia	not available	2	33	27	not available	PDD3	2 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Control	not available	2	48	12	not available	Ctrl3	3 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Dementia with Lewy bodies	not available	4	29	20	not available	DLB3	4 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Female	Parkinson's disease with dementia	not available	2	24	28	not available	PDD4	5 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Male	Dementia with Lewy bodies	not available	3	38	21	not available	DLB4	6 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	6	30	3	not available	AD3	7 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Male	Control	not available	0	21.5	13	not available	Ctrl4	8 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Alzheimer's disease	not available	6	14	4	not available	AD4	9 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD4	not available	INTSTD4	10 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD3	not available	INTSTD3	1 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Parkinson's disease with dementia	not available	2	33	27	not available	PDD3	2 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Control	not available	2	48	12	not available	Ctrl3	3 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Dementia with Lewy bodies	not available	4	29	20	not available	DLB3	4 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Female	Parkinson's disease with dementia	not available	2	24	28	not available	PDD4	5 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Male	Dementia with Lewy bodies	not available	3	38	21	not available	DLB4	6 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	6	30	3	not available	AD3	7 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Male	Control	not available	0	21.5	13	not available	Ctrl4	8 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Alzheimer's disease	not available	6	14	4	not available	AD4	9 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD4	not available	INTSTD4	10 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD3	not available	INTSTD3	1 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Parkinson's disease with dementia	not available	2	33	27	not available	PDD3	2 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Male	Control	not available	2	48	12	not available	Ctrl3	3 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	Female	Dementia with Lewy bodies	not available	4	29	20	not available	DLB3	4 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Female	Parkinson's disease with dementia	not available	2	24	28	not available	PDD4	5 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	1	Parkinson's disease with dementia
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	Male	Dementia with Lewy bodies	not available	3	38	21	not available	DLB4	6 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	1	Dementia with Lewy bodies
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Alzheimer's disease	not available	6	30	3	not available	AD3	7 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Male	Control	not available	0	21.5	13	not available	Ctrl4	8 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	1	Control
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Alzheimer's disease	not available	6	14	4	not available	AD4	9 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	1	Alzheimer's disease
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD4	not available	INTSTD4	10 PXD006122-Sample-2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD5	not available	INTSTD5	1 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Dementia with Lewy bodies	not available	4	13.5	22	not available	DLB5	2 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Parkinson's disease with dementia	not available	2	24	29	not available	PDD5	3 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	17.5	5	not available	AD5	4 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Dementia with Lewy bodies	not available	2	8	23	not available	DLB6	5 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Control	not available	0	43	14	not available	Ctrl5	6 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	29	6	not available	AD6	7 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Control	not available	2	6	15	not available	Ctrl6	8 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Parkinson's disease with dementia	not available	0	32	30	not available	PDD6	9 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD6	not available	INTSTD6	10 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD5	not available	INTSTD5	1 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Dementia with Lewy bodies	not available	4	13.5	22	not available	DLB5	2 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Parkinson's disease with dementia	not available	2	24	29	not available	PDD5	3 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	17.5	5	not available	AD5	4 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Dementia with Lewy bodies	not available	2	8	23	not available	DLB6	5 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Control	not available	0	43	14	not available	Ctrl5	6 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	29	6	not available	AD6	7 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Control	not available	2	6	15	not available	Ctrl6	8 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Parkinson's disease with dementia	not available	0	32	30	not available	PDD6	9 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD6	not available	INTSTD6	10 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD5	not available	INTSTD5	1 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Dementia with Lewy bodies	not available	4	13.5	22	not available	DLB5	2 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Parkinson's disease with dementia	not available	2	24	29	not available	PDD5	3 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	17.5	5	not available	AD5	4 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Dementia with Lewy bodies	not available	2	8	23	not available	DLB6	5 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Control	not available	0	43	14	not available	Ctrl5	6 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	29	6	not available	AD6	7 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Control	not available	2	6	15	not available	Ctrl6	8 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Parkinson's disease with dementia	not available	0	32	30	not available	PDD6	9 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD6	not available	INTSTD6	10 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD5	not available	INTSTD5	1 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Dementia with Lewy bodies	not available	4	13.5	22	not available	DLB5	2 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Parkinson's disease with dementia	not available	2	24	29	not available	PDD5	3 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	17.5	5	not available	AD5	4 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Dementia with Lewy bodies	not available	2	8	23	not available	DLB6	5 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Control	not available	0	43	14	not available	Ctrl5	6 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	29	6	not available	AD6	7 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Control	not available	2	6	15	not available	Ctrl6	8 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Parkinson's disease with dementia	not available	0	32	30	not available	PDD6	9 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD6	not available	INTSTD6	10 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD5	not available	INTSTD5	1 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Dementia with Lewy bodies	not available	4	13.5	22	not available	DLB5	2 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Parkinson's disease with dementia	not available	2	24	29	not available	PDD5	3 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	17.5	5	not available	AD5	4 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Dementia with Lewy bodies	not available	2	8	23	not available	DLB6	5 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Control	not available	0	43	14	not available	Ctrl5	6 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	29	6	not available	AD6	7 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Control	not available	2	6	15	not available	Ctrl6	8 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Parkinson's disease with dementia	not available	0	32	30	not available	PDD6	9 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD6	not available	INTSTD6	10 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD5	not available	INTSTD5	1 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Dementia with Lewy bodies	not available	4	13.5	22	not available	DLB5	2 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Parkinson's disease with dementia	not available	2	24	29	not available	PDD5	3 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	17.5	5	not available	AD5	4 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Dementia with Lewy bodies	not available	2	8	23	not available	DLB6	5 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Control	not available	0	43	14	not available	Ctrl5	6 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	29	6	not available	AD6	7 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Control	not available	2	6	15	not available	Ctrl6	8 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Parkinson's disease with dementia	not available	0	32	30	not available	PDD6	9 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD6	not available	INTSTD6	10 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD5	not available	INTSTD5	1 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Dementia with Lewy bodies	not available	4	13.5	22	not available	DLB5	2 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Parkinson's disease with dementia	not available	2	24	29	not available	PDD5	3 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	17.5	5	not available	AD5	4 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Dementia with Lewy bodies	not available	2	8	23	not available	DLB6	5 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Control	not available	0	43	14	not available	Ctrl5	6 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	29	6	not available	AD6	7 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Control	not available	2	6	15	not available	Ctrl6	8 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Parkinson's disease with dementia	not available	0	32	30	not available	PDD6	9 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD6	not available	INTSTD6	10 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD5	not available	INTSTD5	1 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Dementia with Lewy bodies	not available	4	13.5	22	not available	DLB5	2 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Parkinson's disease with dementia	not available	2	24	29	not available	PDD5	3 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	17.5	5	not available	AD5	4 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Dementia with Lewy bodies	not available	2	8	23	not available	DLB6	5 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Control	not available	0	43	14	not available	Ctrl5	6 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	29	6	not available	AD6	7 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Control	not available	2	6	15	not available	Ctrl6	8 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Parkinson's disease with dementia	not available	0	32	30	not available	PDD6	9 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD6	not available	INTSTD6	10 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD5	not available	INTSTD5	1 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Dementia with Lewy bodies	not available	4	13.5	22	not available	DLB5	2 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Parkinson's disease with dementia	not available	2	24	29	not available	PDD5	3 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	17.5	5	not available	AD5	4 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Dementia with Lewy bodies	not available	2	8	23	not available	DLB6	5 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Control	not available	0	43	14	not available	Ctrl5	6 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	29	6	not available	AD6	7 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Control	not available	2	6	15	not available	Ctrl6	8 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Parkinson's disease with dementia	not available	0	32	30	not available	PDD6	9 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD6	not available	INTSTD6	10 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD5	not available	INTSTD5	1 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Dementia with Lewy bodies	not available	4	13.5	22	not available	DLB5	2 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Parkinson's disease with dementia	not available	2	24	29	not available	PDD5	3 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	17.5	5	not available	AD5	4 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Dementia with Lewy bodies	not available	2	8	23	not available	DLB6	5 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Control	not available	0	43	14	not available	Ctrl5	6 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	29	6	not available	AD6	7 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Control	not available	2	6	15	not available	Ctrl6	8 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Parkinson's disease with dementia	not available	0	32	30	not available	PDD6	9 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD6	not available	INTSTD6	10 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD5	not available	INTSTD5	1 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Dementia with Lewy bodies	not available	4	13.5	22	not available	DLB5	2 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Parkinson's disease with dementia	not available	2	24	29	not available	PDD5	3 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	17.5	5	not available	AD5	4 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Dementia with Lewy bodies	not available	2	8	23	not available	DLB6	5 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Control	not available	0	43	14	not available	Ctrl5	6 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	29	6	not available	AD6	7 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Control	not available	2	6	15	not available	Ctrl6	8 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Parkinson's disease with dementia	not available	0	32	30	not available	PDD6	9 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD6	not available	INTSTD6	10 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD5	not available	INTSTD5	1 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Dementia with Lewy bodies	not available	4	13.5	22	not available	DLB5	2 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Parkinson's disease with dementia	not available	2	24	29	not available	PDD5	3 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	17.5	5	not available	AD5	4 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Dementia with Lewy bodies	not available	2	8	23	not available	DLB6	5 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Control	not available	0	43	14	not available	Ctrl5	6 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	29	6	not available	AD6	7 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Control	not available	2	6	15	not available	Ctrl6	8 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Parkinson's disease with dementia	not available	0	32	30	not available	PDD6	9 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD6	not available	INTSTD6	10 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD5	not available	INTSTD5	1 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Dementia with Lewy bodies	not available	4	13.5	22	not available	DLB5	2 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Parkinson's disease with dementia	not available	2	24	29	not available	PDD5	3 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	17.5	5	not available	AD5	4 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Dementia with Lewy bodies	not available	2	8	23	not available	DLB6	5 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Control	not available	0	43	14	not available	Ctrl5	6 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	29	6	not available	AD6	7 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Control	not available	2	6	15	not available	Ctrl6	8 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Parkinson's disease with dementia	not available	0	32	30	not available	PDD6	9 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD6	not available	INTSTD6	10 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD5	not available	INTSTD5	1 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Dementia with Lewy bodies	not available	4	13.5	22	not available	DLB5	2 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Parkinson's disease with dementia	not available	2	24	29	not available	PDD5	3 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	17.5	5	not available	AD5	4 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Dementia with Lewy bodies	not available	2	8	23	not available	DLB6	5 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Control	not available	0	43	14	not available	Ctrl5	6 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	29	6	not available	AD6	7 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Control	not available	2	6	15	not available	Ctrl6	8 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Parkinson's disease with dementia	not available	0	32	30	not available	PDD6	9 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD6	not available	INTSTD6	10 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD5	not available	INTSTD5	1 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Dementia with Lewy bodies	not available	4	13.5	22	not available	DLB5	2 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Parkinson's disease with dementia	not available	2	24	29	not available	PDD5	3 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	17.5	5	not available	AD5	4 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Dementia with Lewy bodies	not available	2	8	23	not available	DLB6	5 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Control	not available	0	43	14	not available	Ctrl5	6 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	29	6	not available	AD6	7 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Control	not available	2	6	15	not available	Ctrl6	8 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Parkinson's disease with dementia	not available	0	32	30	not available	PDD6	9 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD6	not available	INTSTD6	10 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD5	not available	INTSTD5	1 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Dementia with Lewy bodies	not available	4	13.5	22	not available	DLB5	2 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Parkinson's disease with dementia	not available	2	24	29	not available	PDD5	3 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	17.5	5	not available	AD5	4 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Dementia with Lewy bodies	not available	2	8	23	not available	DLB6	5 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Control	not available	0	43	14	not available	Ctrl5	6 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	29	6	not available	AD6	7 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Control	not available	2	6	15	not available	Ctrl6	8 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Parkinson's disease with dementia	not available	0	32	30	not available	PDD6	9 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD6	not available	INTSTD6	10 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD5	not available	INTSTD5	1 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Dementia with Lewy bodies	not available	4	13.5	22	not available	DLB5	2 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Parkinson's disease with dementia	not available	2	24	29	not available	PDD5	3 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	17.5	5	not available	AD5	4 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Dementia with Lewy bodies	not available	2	8	23	not available	DLB6	5 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Control	not available	0	43	14	not available	Ctrl5	6 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	29	6	not available	AD6	7 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Control	not available	2	6	15	not available	Ctrl6	8 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Parkinson's disease with dementia	not available	0	32	30	not available	PDD6	9 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD6	not available	INTSTD6	10 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD5	not available	INTSTD5	1 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Dementia with Lewy bodies	not available	4	13.5	22	not available	DLB5	2 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Parkinson's disease with dementia	not available	2	24	29	not available	PDD5	3 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	17.5	5	not available	AD5	4 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Dementia with Lewy bodies	not available	2	8	23	not available	DLB6	5 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Control	not available	0	43	14	not available	Ctrl5	6 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	29	6	not available	AD6	7 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Control	not available	2	6	15	not available	Ctrl6	8 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Parkinson's disease with dementia	not available	0	32	30	not available	PDD6	9 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD6	not available	INTSTD6	10 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD5	not available	INTSTD5	1 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Dementia with Lewy bodies	not available	4	13.5	22	not available	DLB5	2 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Parkinson's disease with dementia	not available	2	24	29	not available	PDD5	3 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	17.5	5	not available	AD5	4 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Dementia with Lewy bodies	not available	2	8	23	not available	DLB6	5 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Control	not available	0	43	14	not available	Ctrl5	6 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	29	6	not available	AD6	7 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Control	not available	2	6	15	not available	Ctrl6	8 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Parkinson's disease with dementia	not available	0	32	30	not available	PDD6	9 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD6	not available	INTSTD6	10 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD5	not available	INTSTD5	1 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Dementia with Lewy bodies	not available	4	13.5	22	not available	DLB5	2 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Parkinson's disease with dementia	not available	2	24	29	not available	PDD5	3 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	17.5	5	not available	AD5	4 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Dementia with Lewy bodies	not available	2	8	23	not available	DLB6	5 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Control	not available	0	43	14	not available	Ctrl5	6 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	29	6	not available	AD6	7 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Control	not available	2	6	15	not available	Ctrl6	8 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Parkinson's disease with dementia	not available	0	32	30	not available	PDD6	9 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD6	not available	INTSTD6	10 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD5	not available	INTSTD5	1 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Dementia with Lewy bodies	not available	4	13.5	22	not available	DLB5	2 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Parkinson's disease with dementia	not available	2	24	29	not available	PDD5	3 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	17.5	5	not available	AD5	4 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Dementia with Lewy bodies	not available	2	8	23	not available	DLB6	5 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Control	not available	0	43	14	not available	Ctrl5	6 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	29	6	not available	AD6	7 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Control	not available	2	6	15	not available	Ctrl6	8 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Parkinson's disease with dementia	not available	0	32	30	not available	PDD6	9 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD6	not available	INTSTD6	10 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD5	not available	INTSTD5	1 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Dementia with Lewy bodies	not available	4	13.5	22	not available	DLB5	2 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Parkinson's disease with dementia	not available	2	24	29	not available	PDD5	3 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	17.5	5	not available	AD5	4 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Dementia with Lewy bodies	not available	2	8	23	not available	DLB6	5 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Control	not available	0	43	14	not available	Ctrl5	6 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	29	6	not available	AD6	7 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Control	not available	2	6	15	not available	Ctrl6	8 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Parkinson's disease with dementia	not available	0	32	30	not available	PDD6	9 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD6	not available	INTSTD6	10 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD5	not available	INTSTD5	1 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Dementia with Lewy bodies	not available	4	13.5	22	not available	DLB5	2 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Parkinson's disease with dementia	not available	2	24	29	not available	PDD5	3 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	17.5	5	not available	AD5	4 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Dementia with Lewy bodies	not available	2	8	23	not available	DLB6	5 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Control	not available	0	43	14	not available	Ctrl5	6 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	29	6	not available	AD6	7 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Control	not available	2	6	15	not available	Ctrl6	8 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Parkinson's disease with dementia	not available	0	32	30	not available	PDD6	9 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD6	not available	INTSTD6	10 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD5	not available	INTSTD5	1 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Dementia with Lewy bodies	not available	4	13.5	22	not available	DLB5	2 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Parkinson's disease with dementia	not available	2	24	29	not available	PDD5	3 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	17.5	5	not available	AD5	4 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Dementia with Lewy bodies	not available	2	8	23	not available	DLB6	5 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Control	not available	0	43	14	not available	Ctrl5	6 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	29	6	not available	AD6	7 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Control	not available	2	6	15	not available	Ctrl6	8 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Parkinson's disease with dementia	not available	0	32	30	not available	PDD6	9 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD6	not available	INTSTD6	10 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD5	not available	INTSTD5	1 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Dementia with Lewy bodies	not available	4	13.5	22	not available	DLB5	2 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Parkinson's disease with dementia	not available	2	24	29	not available	PDD5	3 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	17.5	5	not available	AD5	4 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Dementia with Lewy bodies	not available	2	8	23	not available	DLB6	5 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Control	not available	0	43	14	not available	Ctrl5	6 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	29	6	not available	AD6	7 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Control	not available	2	6	15	not available	Ctrl6	8 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Parkinson's disease with dementia	not available	0	32	30	not available	PDD6	9 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD6	not available	INTSTD6	10 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD5	not available	INTSTD5	1 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Dementia with Lewy bodies	not available	4	13.5	22	not available	DLB5	2 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Parkinson's disease with dementia	not available	2	24	29	not available	PDD5	3 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	17.5	5	not available	AD5	4 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Dementia with Lewy bodies	not available	2	8	23	not available	DLB6	5 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Control	not available	0	43	14	not available	Ctrl5	6 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	29	6	not available	AD6	7 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Control	not available	2	6	15	not available	Ctrl6	8 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Parkinson's disease with dementia	not available	0	32	30	not available	PDD6	9 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD6	not available	INTSTD6	10 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD5	not available	INTSTD5	1 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Dementia with Lewy bodies	not available	4	13.5	22	not available	DLB5	2 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Parkinson's disease with dementia	not available	2	24	29	not available	PDD5	3 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	17.5	5	not available	AD5	4 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Dementia with Lewy bodies	not available	2	8	23	not available	DLB6	5 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Control	not available	0	43	14	not available	Ctrl5	6 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	29	6	not available	AD6	7 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Control	not available	2	6	15	not available	Ctrl6	8 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Parkinson's disease with dementia	not available	0	32	30	not available	PDD6	9 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD6	not available	INTSTD6	10 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD5	not available	INTSTD5	1 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Dementia with Lewy bodies	not available	4	13.5	22	not available	DLB5	2 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Parkinson's disease with dementia	not available	2	24	29	not available	PDD5	3 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	17.5	5	not available	AD5	4 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Dementia with Lewy bodies	not available	2	8	23	not available	DLB6	5 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Control	not available	0	43	14	not available	Ctrl5	6 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	29	6	not available	AD6	7 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Control	not available	2	6	15	not available	Ctrl6	8 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Parkinson's disease with dementia	not available	0	32	30	not available	PDD6	9 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD6	not available	INTSTD6	10 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD5	not available	INTSTD5	1 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Dementia with Lewy bodies	not available	4	13.5	22	not available	DLB5	2 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Parkinson's disease with dementia	not available	2	24	29	not available	PDD5	3 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	17.5	5	not available	AD5	4 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Dementia with Lewy bodies	not available	2	8	23	not available	DLB6	5 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Control	not available	0	43	14	not available	Ctrl5	6 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	29	6	not available	AD6	7 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Control	not available	2	6	15	not available	Ctrl6	8 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Parkinson's disease with dementia	not available	0	32	30	not available	PDD6	9 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD6	not available	INTSTD6	10 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD5	not available	INTSTD5	1 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Dementia with Lewy bodies	not available	4	13.5	22	not available	DLB5	2 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Parkinson's disease with dementia	not available	2	24	29	not available	PDD5	3 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	17.5	5	not available	AD5	4 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Dementia with Lewy bodies	not available	2	8	23	not available	DLB6	5 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Control	not available	0	43	14	not available	Ctrl5	6 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	29	6	not available	AD6	7 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Control	not available	2	6	15	not available	Ctrl6	8 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Parkinson's disease with dementia	not available	0	32	30	not available	PDD6	9 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD6	not available	INTSTD6	10 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD5	not available	INTSTD5	1 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Dementia with Lewy bodies	not available	4	13.5	22	not available	DLB5	2 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Parkinson's disease with dementia	not available	2	24	29	not available	PDD5	3 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	17.5	5	not available	AD5	4 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Dementia with Lewy bodies	not available	2	8	23	not available	DLB6	5 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Control	not available	0	43	14	not available	Ctrl5	6 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	29	6	not available	AD6	7 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Control	not available	2	6	15	not available	Ctrl6	8 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Parkinson's disease with dementia	not available	0	32	30	not available	PDD6	9 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD6	not available	INTSTD6	10 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD5	not available	INTSTD5	1 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Dementia with Lewy bodies	not available	4	13.5	22	not available	DLB5	2 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Parkinson's disease with dementia	not available	2	24	29	not available	PDD5	3 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	17.5	5	not available	AD5	4 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Dementia with Lewy bodies	not available	2	8	23	not available	DLB6	5 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Control	not available	0	43	14	not available	Ctrl5	6 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	29	6	not available	AD6	7 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Control	not available	2	6	15	not available	Ctrl6	8 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Parkinson's disease with dementia	not available	0	32	30	not available	PDD6	9 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD6	not available	INTSTD6	10 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD5	not available	INTSTD5	1 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Dementia with Lewy bodies	not available	4	13.5	22	not available	DLB5	2 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Parkinson's disease with dementia	not available	2	24	29	not available	PDD5	3 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	17.5	5	not available	AD5	4 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Dementia with Lewy bodies	not available	2	8	23	not available	DLB6	5 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Control	not available	0	43	14	not available	Ctrl5	6 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	29	6	not available	AD6	7 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Control	not available	2	6	15	not available	Ctrl6	8 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Parkinson's disease with dementia	not available	0	32	30	not available	PDD6	9 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD6	not available	INTSTD6	10 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD5	not available	INTSTD5	1 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Dementia with Lewy bodies	not available	4	13.5	22	not available	DLB5	2 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Parkinson's disease with dementia	not available	2	24	29	not available	PDD5	3 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	17.5	5	not available	AD5	4 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Dementia with Lewy bodies	not available	2	8	23	not available	DLB6	5 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Control	not available	0	43	14	not available	Ctrl5	6 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	29	6	not available	AD6	7 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Control	not available	2	6	15	not available	Ctrl6	8 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Parkinson's disease with dementia	not available	0	32	30	not available	PDD6	9 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD6	not available	INTSTD6	10 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD5	not available	INTSTD5	1 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Dementia with Lewy bodies	not available	4	13.5	22	not available	DLB5	2 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Parkinson's disease with dementia	not available	2	24	29	not available	PDD5	3 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	17.5	5	not available	AD5	4 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Dementia with Lewy bodies	not available	2	8	23	not available	DLB6	5 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Control	not available	0	43	14	not available	Ctrl5	6 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	29	6	not available	AD6	7 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Control	not available	2	6	15	not available	Ctrl6	8 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Parkinson's disease with dementia	not available	0	32	30	not available	PDD6	9 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD6	not available	INTSTD6	10 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD5	not available	INTSTD5	1 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Dementia with Lewy bodies	not available	4	13.5	22	not available	DLB5	2 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Parkinson's disease with dementia	not available	2	24	29	not available	PDD5	3 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	17.5	5	not available	AD5	4 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Dementia with Lewy bodies	not available	2	8	23	not available	DLB6	5 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Control	not available	0	43	14	not available	Ctrl5	6 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	29	6	not available	AD6	7 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Control	not available	2	6	15	not available	Ctrl6	8 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Parkinson's disease with dementia	not available	0	32	30	not available	PDD6	9 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD6	not available	INTSTD6	10 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD5	not available	INTSTD5	1 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Dementia with Lewy bodies	not available	4	13.5	22	not available	DLB5	2 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Parkinson's disease with dementia	not available	2	24	29	not available	PDD5	3 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	17.5	5	not available	AD5	4 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Dementia with Lewy bodies	not available	2	8	23	not available	DLB6	5 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Control	not available	0	43	14	not available	Ctrl5	6 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	29	6	not available	AD6	7 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Control	not available	2	6	15	not available	Ctrl6	8 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Parkinson's disease with dementia	not available	0	32	30	not available	PDD6	9 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD6	not available	INTSTD6	10 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD5	not available	INTSTD5	1 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Dementia with Lewy bodies	not available	4	13.5	22	not available	DLB5	2 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Parkinson's disease with dementia	not available	2	24	29	not available	PDD5	3 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	17.5	5	not available	AD5	4 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Dementia with Lewy bodies	not available	2	8	23	not available	DLB6	5 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Control	not available	0	43	14	not available	Ctrl5	6 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	29	6	not available	AD6	7 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Control	not available	2	6	15	not available	Ctrl6	8 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Parkinson's disease with dementia	not available	0	32	30	not available	PDD6	9 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD6	not available	INTSTD6	10 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD5	not available	INTSTD5	1 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Dementia with Lewy bodies	not available	4	13.5	22	not available	DLB5	2 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Parkinson's disease with dementia	not available	2	24	29	not available	PDD5	3 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	17.5	5	not available	AD5	4 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Dementia with Lewy bodies	not available	2	8	23	not available	DLB6	5 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Control	not available	0	43	14	not available	Ctrl5	6 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	29	6	not available	AD6	7 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Control	not available	2	6	15	not available	Ctrl6	8 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Parkinson's disease with dementia	not available	0	32	30	not available	PDD6	9 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD6	not available	INTSTD6	10 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD5	not available	INTSTD5	1 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Dementia with Lewy bodies	not available	4	13.5	22	not available	DLB5	2 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Parkinson's disease with dementia	not available	2	24	29	not available	PDD5	3 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	17.5	5	not available	AD5	4 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Dementia with Lewy bodies	not available	2	8	23	not available	DLB6	5 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Control	not available	0	43	14	not available	Ctrl5	6 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	29	6	not available	AD6	7 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Control	not available	2	6	15	not available	Ctrl6	8 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Parkinson's disease with dementia	not available	0	32	30	not available	PDD6	9 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD6	not available	INTSTD6	10 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD5	not available	INTSTD5	1 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Dementia with Lewy bodies	not available	4	13.5	22	not available	DLB5	2 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Parkinson's disease with dementia	not available	2	24	29	not available	PDD5	3 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	17.5	5	not available	AD5	4 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Dementia with Lewy bodies	not available	2	8	23	not available	DLB6	5 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Control	not available	0	43	14	not available	Ctrl5	6 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	29	6	not available	AD6	7 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Control	not available	2	6	15	not available	Ctrl6	8 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Parkinson's disease with dementia	not available	0	32	30	not available	PDD6	9 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD6	not available	INTSTD6	10 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD5	not available	INTSTD5	1 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Dementia with Lewy bodies	not available	4	13.5	22	not available	DLB5	2 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Parkinson's disease with dementia	not available	2	24	29	not available	PDD5	3 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	17.5	5	not available	AD5	4 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Dementia with Lewy bodies	not available	2	8	23	not available	DLB6	5 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Control	not available	0	43	14	not available	Ctrl5	6 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	29	6	not available	AD6	7 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Control	not available	2	6	15	not available	Ctrl6	8 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Parkinson's disease with dementia	not available	0	32	30	not available	PDD6	9 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD6	not available	INTSTD6	10 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD5	not available	INTSTD5	1 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Dementia with Lewy bodies	not available	4	13.5	22	not available	DLB5	2 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Parkinson's disease with dementia	not available	2	24	29	not available	PDD5	3 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	17.5	5	not available	AD5	4 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Dementia with Lewy bodies	not available	2	8	23	not available	DLB6	5 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Control	not available	0	43	14	not available	Ctrl5	6 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	29	6	not available	AD6	7 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Control	not available	2	6	15	not available	Ctrl6	8 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Parkinson's disease with dementia	not available	0	32	30	not available	PDD6	9 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD6	not available	INTSTD6	10 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD5	not available	INTSTD5	1 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Dementia with Lewy bodies	not available	4	13.5	22	not available	DLB5	2 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Parkinson's disease with dementia	not available	2	24	29	not available	PDD5	3 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	17.5	5	not available	AD5	4 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Dementia with Lewy bodies	not available	2	8	23	not available	DLB6	5 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Control	not available	0	43	14	not available	Ctrl5	6 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	29	6	not available	AD6	7 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Control	not available	2	6	15	not available	Ctrl6	8 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Parkinson's disease with dementia	not available	0	32	30	not available	PDD6	9 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD6	not available	INTSTD6	10 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD5	not available	INTSTD5	1 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Dementia with Lewy bodies	not available	4	13.5	22	not available	DLB5	2 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Parkinson's disease with dementia	not available	2	24	29	not available	PDD5	3 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	17.5	5	not available	AD5	4 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Dementia with Lewy bodies	not available	2	8	23	not available	DLB6	5 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Control	not available	0	43	14	not available	Ctrl5	6 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	29	6	not available	AD6	7 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Control	not available	2	6	15	not available	Ctrl6	8 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Parkinson's disease with dementia	not available	0	32	30	not available	PDD6	9 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD6	not available	INTSTD6	10 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD5	not available	INTSTD5	1 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Dementia with Lewy bodies	not available	4	13.5	22	not available	DLB5	2 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Parkinson's disease with dementia	not available	2	24	29	not available	PDD5	3 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	17.5	5	not available	AD5	4 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Dementia with Lewy bodies	not available	2	8	23	not available	DLB6	5 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Control	not available	0	43	14	not available	Ctrl5	6 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	29	6	not available	AD6	7 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Control	not available	2	6	15	not available	Ctrl6	8 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Parkinson's disease with dementia	not available	0	32	30	not available	PDD6	9 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD6	not available	INTSTD6	10 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD5	not available	INTSTD5	1 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Dementia with Lewy bodies	not available	4	13.5	22	not available	DLB5	2 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Parkinson's disease with dementia	not available	2	24	29	not available	PDD5	3 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	17.5	5	not available	AD5	4 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Dementia with Lewy bodies	not available	2	8	23	not available	DLB6	5 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Control	not available	0	43	14	not available	Ctrl5	6 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	29	6	not available	AD6	7 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Control	not available	2	6	15	not available	Ctrl6	8 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Parkinson's disease with dementia	not available	0	32	30	not available	PDD6	9 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD6	not available	INTSTD6	10 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD5	not available	INTSTD5	1 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Dementia with Lewy bodies	not available	4	13.5	22	not available	DLB5	2 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Parkinson's disease with dementia	not available	2	24	29	not available	PDD5	3 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	17.5	5	not available	AD5	4 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Dementia with Lewy bodies	not available	2	8	23	not available	DLB6	5 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Control	not available	0	43	14	not available	Ctrl5	6 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	29	6	not available	AD6	7 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Control	not available	2	6	15	not available	Ctrl6	8 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Parkinson's disease with dementia	not available	0	32	30	not available	PDD6	9 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD6	not available	INTSTD6	10 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD5	not available	INTSTD5	1 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Dementia with Lewy bodies	not available	4	13.5	22	not available	DLB5	2 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Parkinson's disease with dementia	not available	2	24	29	not available	PDD5	3 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	17.5	5	not available	AD5	4 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Dementia with Lewy bodies	not available	2	8	23	not available	DLB6	5 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Control	not available	0	43	14	not available	Ctrl5	6 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	29	6	not available	AD6	7 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Control	not available	2	6	15	not available	Ctrl6	8 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Parkinson's disease with dementia	not available	0	32	30	not available	PDD6	9 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD6	not available	INTSTD6	10 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD5	not available	INTSTD5	1 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Dementia with Lewy bodies	not available	4	13.5	22	not available	DLB5	2 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Parkinson's disease with dementia	not available	2	24	29	not available	PDD5	3 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	17.5	5	not available	AD5	4 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Dementia with Lewy bodies	not available	2	8	23	not available	DLB6	5 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Control	not available	0	43	14	not available	Ctrl5	6 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	29	6	not available	AD6	7 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Control	not available	2	6	15	not available	Ctrl6	8 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Parkinson's disease with dementia	not available	0	32	30	not available	PDD6	9 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD6	not available	INTSTD6	10 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD5	not available	INTSTD5	1 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Dementia with Lewy bodies	not available	4	13.5	22	not available	DLB5	2 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Parkinson's disease with dementia	not available	2	24	29	not available	PDD5	3 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	17.5	5	not available	AD5	4 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Dementia with Lewy bodies	not available	2	8	23	not available	DLB6	5 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Control	not available	0	43	14	not available	Ctrl5	6 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	29	6	not available	AD6	7 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Control	not available	2	6	15	not available	Ctrl6	8 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Parkinson's disease with dementia	not available	0	32	30	not available	PDD6	9 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD6	not available	INTSTD6	10 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD5	not available	INTSTD5	1 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Dementia with Lewy bodies	not available	4	13.5	22	not available	DLB5	2 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Parkinson's disease with dementia	not available	2	24	29	not available	PDD5	3 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	17.5	5	not available	AD5	4 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Dementia with Lewy bodies	not available	2	8	23	not available	DLB6	5 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Control	not available	0	43	14	not available	Ctrl5	6 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	29	6	not available	AD6	7 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Control	not available	2	6	15	not available	Ctrl6	8 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Parkinson's disease with dementia	not available	0	32	30	not available	PDD6	9 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD6	not available	INTSTD6	10 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD5	not available	INTSTD5	1 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Dementia with Lewy bodies	not available	4	13.5	22	not available	DLB5	2 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Parkinson's disease with dementia	not available	2	24	29	not available	PDD5	3 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	17.5	5	not available	AD5	4 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Dementia with Lewy bodies	not available	2	8	23	not available	DLB6	5 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Control	not available	0	43	14	not available	Ctrl5	6 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	29	6	not available	AD6	7 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Control	not available	2	6	15	not available	Ctrl6	8 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Parkinson's disease with dementia	not available	0	32	30	not available	PDD6	9 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD6	not available	INTSTD6	10 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD5	not available	INTSTD5	1 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Dementia with Lewy bodies	not available	4	13.5	22	not available	DLB5	2 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Parkinson's disease with dementia	not available	2	24	29	not available	PDD5	3 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	17.5	5	not available	AD5	4 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Dementia with Lewy bodies	not available	2	8	23	not available	DLB6	5 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Control	not available	0	43	14	not available	Ctrl5	6 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	29	6	not available	AD6	7 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Control	not available	2	6	15	not available	Ctrl6	8 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Parkinson's disease with dementia	not available	0	32	30	not available	PDD6	9 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD6	not available	INTSTD6	10 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD5	not available	INTSTD5	1 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Dementia with Lewy bodies	not available	4	13.5	22	not available	DLB5	2 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Parkinson's disease with dementia	not available	2	24	29	not available	PDD5	3 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	17.5	5	not available	AD5	4 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Dementia with Lewy bodies	not available	2	8	23	not available	DLB6	5 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Control	not available	0	43	14	not available	Ctrl5	6 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	29	6	not available	AD6	7 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Control	not available	2	6	15	not available	Ctrl6	8 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Parkinson's disease with dementia	not available	0	32	30	not available	PDD6	9 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD6	not available	INTSTD6	10 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD5	not available	INTSTD5	1 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Dementia with Lewy bodies	not available	4	13.5	22	not available	DLB5	2 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Parkinson's disease with dementia	not available	2	24	29	not available	PDD5	3 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	17.5	5	not available	AD5	4 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Dementia with Lewy bodies	not available	2	8	23	not available	DLB6	5 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Control	not available	0	43	14	not available	Ctrl5	6 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	29	6	not available	AD6	7 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Control	not available	2	6	15	not available	Ctrl6	8 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Parkinson's disease with dementia	not available	0	32	30	not available	PDD6	9 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD6	not available	INTSTD6	10 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD5	not available	INTSTD5	1 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Dementia with Lewy bodies	not available	4	13.5	22	not available	DLB5	2 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Parkinson's disease with dementia	not available	2	24	29	not available	PDD5	3 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	17.5	5	not available	AD5	4 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Dementia with Lewy bodies	not available	2	8	23	not available	DLB6	5 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Control	not available	0	43	14	not available	Ctrl5	6 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	29	6	not available	AD6	7 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Control	not available	2	6	15	not available	Ctrl6	8 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Parkinson's disease with dementia	not available	0	32	30	not available	PDD6	9 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD6	not available	INTSTD6	10 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD5	not available	INTSTD5	1 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Dementia with Lewy bodies	not available	4	13.5	22	not available	DLB5	2 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Parkinson's disease with dementia	not available	2	24	29	not available	PDD5	3 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	17.5	5	not available	AD5	4 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Dementia with Lewy bodies	not available	2	8	23	not available	DLB6	5 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Control	not available	0	43	14	not available	Ctrl5	6 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	29	6	not available	AD6	7 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Control	not available	2	6	15	not available	Ctrl6	8 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Parkinson's disease with dementia	not available	0	32	30	not available	PDD6	9 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD6	not available	INTSTD6	10 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD5	not available	INTSTD5	1 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Dementia with Lewy bodies	not available	4	13.5	22	not available	DLB5	2 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Parkinson's disease with dementia	not available	2	24	29	not available	PDD5	3 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	17.5	5	not available	AD5	4 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Dementia with Lewy bodies	not available	2	8	23	not available	DLB6	5 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Control	not available	0	43	14	not available	Ctrl5	6 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	29	6	not available	AD6	7 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Control	not available	2	6	15	not available	Ctrl6	8 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Parkinson's disease with dementia	not available	0	32	30	not available	PDD6	9 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD6	not available	INTSTD6	10 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD5	not available	INTSTD5	1 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Dementia with Lewy bodies	not available	4	13.5	22	not available	DLB5	2 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Parkinson's disease with dementia	not available	2	24	29	not available	PDD5	3 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	17.5	5	not available	AD5	4 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Dementia with Lewy bodies	not available	2	8	23	not available	DLB6	5 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Control	not available	0	43	14	not available	Ctrl5	6 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	29	6	not available	AD6	7 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Control	not available	2	6	15	not available	Ctrl6	8 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Parkinson's disease with dementia	not available	0	32	30	not available	PDD6	9 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD6	not available	INTSTD6	10 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD5	not available	INTSTD5	1 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Dementia with Lewy bodies	not available	4	13.5	22	not available	DLB5	2 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Parkinson's disease with dementia	not available	2	24	29	not available	PDD5	3 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	17.5	5	not available	AD5	4 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Dementia with Lewy bodies	not available	2	8	23	not available	DLB6	5 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Control	not available	0	43	14	not available	Ctrl5	6 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	29	6	not available	AD6	7 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Control	not available	2	6	15	not available	Ctrl6	8 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Parkinson's disease with dementia	not available	0	32	30	not available	PDD6	9 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD6	not available	INTSTD6	10 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD5	not available	INTSTD5	1 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Dementia with Lewy bodies	not available	4	13.5	22	not available	DLB5	2 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Parkinson's disease with dementia	not available	2	24	29	not available	PDD5	3 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	17.5	5	not available	AD5	4 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Dementia with Lewy bodies	not available	2	8	23	not available	DLB6	5 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Control	not available	0	43	14	not available	Ctrl5	6 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	29	6	not available	AD6	7 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Control	not available	2	6	15	not available	Ctrl6	8 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Parkinson's disease with dementia	not available	0	32	30	not available	PDD6	9 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD6	not available	INTSTD6	10 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD5	not available	INTSTD5	1 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Dementia with Lewy bodies	not available	4	13.5	22	not available	DLB5	2 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Parkinson's disease with dementia	not available	2	24	29	not available	PDD5	3 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	17.5	5	not available	AD5	4 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Dementia with Lewy bodies	not available	2	8	23	not available	DLB6	5 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Control	not available	0	43	14	not available	Ctrl5	6 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	29	6	not available	AD6	7 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Control	not available	2	6	15	not available	Ctrl6	8 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Parkinson's disease with dementia	not available	0	32	30	not available	PDD6	9 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD6	not available	INTSTD6	10 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD5	not available	INTSTD5	1 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Dementia with Lewy bodies	not available	4	13.5	22	not available	DLB5	2 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Parkinson's disease with dementia	not available	2	24	29	not available	PDD5	3 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	17.5	5	not available	AD5	4 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Dementia with Lewy bodies	not available	2	8	23	not available	DLB6	5 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Control	not available	0	43	14	not available	Ctrl5	6 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	29	6	not available	AD6	7 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Control	not available	2	6	15	not available	Ctrl6	8 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Parkinson's disease with dementia	not available	0	32	30	not available	PDD6	9 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD6	not available	INTSTD6	10 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD5	not available	INTSTD5	1 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Dementia with Lewy bodies	not available	4	13.5	22	not available	DLB5	2 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Parkinson's disease with dementia	not available	2	24	29	not available	PDD5	3 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	17.5	5	not available	AD5	4 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Dementia with Lewy bodies	not available	2	8	23	not available	DLB6	5 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Control	not available	0	43	14	not available	Ctrl5	6 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	29	6	not available	AD6	7 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Control	not available	2	6	15	not available	Ctrl6	8 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Parkinson's disease with dementia	not available	0	32	30	not available	PDD6	9 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD6	not available	INTSTD6	10 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD5	not available	INTSTD5	1 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Dementia with Lewy bodies	not available	4	13.5	22	not available	DLB5	2 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Parkinson's disease with dementia	not available	2	24	29	not available	PDD5	3 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	17.5	5	not available	AD5	4 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Dementia with Lewy bodies	not available	2	8	23	not available	DLB6	5 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Control	not available	0	43	14	not available	Ctrl5	6 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	29	6	not available	AD6	7 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Control	not available	2	6	15	not available	Ctrl6	8 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Parkinson's disease with dementia	not available	0	32	30	not available	PDD6	9 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD6	not available	INTSTD6	10 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD5	not available	INTSTD5	1 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Dementia with Lewy bodies	not available	4	13.5	22	not available	DLB5	2 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Parkinson's disease with dementia	not available	2	24	29	not available	PDD5	3 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	17.5	5	not available	AD5	4 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Dementia with Lewy bodies	not available	2	8	23	not available	DLB6	5 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Control	not available	0	43	14	not available	Ctrl5	6 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	29	6	not available	AD6	7 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Control	not available	2	6	15	not available	Ctrl6	8 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Parkinson's disease with dementia	not available	0	32	30	not available	PDD6	9 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD6	not available	INTSTD6	10 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD5	not available	INTSTD5	1 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Dementia with Lewy bodies	not available	4	13.5	22	not available	DLB5	2 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Parkinson's disease with dementia	not available	2	24	29	not available	PDD5	3 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	17.5	5	not available	AD5	4 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Dementia with Lewy bodies	not available	2	8	23	not available	DLB6	5 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Control	not available	0	43	14	not available	Ctrl5	6 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	29	6	not available	AD6	7 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Control	not available	2	6	15	not available	Ctrl6	8 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Parkinson's disease with dementia	not available	0	32	30	not available	PDD6	9 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD6	not available	INTSTD6	10 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD5	not available	INTSTD5	1 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Dementia with Lewy bodies	not available	4	13.5	22	not available	DLB5	2 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Parkinson's disease with dementia	not available	2	24	29	not available	PDD5	3 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	17.5	5	not available	AD5	4 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Dementia with Lewy bodies	not available	2	8	23	not available	DLB6	5 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Control	not available	0	43	14	not available	Ctrl5	6 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	29	6	not available	AD6	7 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Control	not available	2	6	15	not available	Ctrl6	8 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Parkinson's disease with dementia	not available	0	32	30	not available	PDD6	9 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD6	not available	INTSTD6	10 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD5	not available	INTSTD5	1 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Dementia with Lewy bodies	not available	4	13.5	22	not available	DLB5	2 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Parkinson's disease with dementia	not available	2	24	29	not available	PDD5	3 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	17.5	5	not available	AD5	4 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Dementia with Lewy bodies	not available	2	8	23	not available	DLB6	5 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Control	not available	0	43	14	not available	Ctrl5	6 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	29	6	not available	AD6	7 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Control	not available	2	6	15	not available	Ctrl6	8 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Parkinson's disease with dementia	not available	0	32	30	not available	PDD6	9 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD6	not available	INTSTD6	10 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD5	not available	INTSTD5	1 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Dementia with Lewy bodies	not available	4	13.5	22	not available	DLB5	2 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Parkinson's disease with dementia	not available	2	24	29	not available	PDD5	3 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	17.5	5	not available	AD5	4 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Dementia with Lewy bodies	not available	2	8	23	not available	DLB6	5 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Control	not available	0	43	14	not available	Ctrl5	6 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	29	6	not available	AD6	7 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Control	not available	2	6	15	not available	Ctrl6	8 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Parkinson's disease with dementia	not available	0	32	30	not available	PDD6	9 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD6	not available	INTSTD6	10 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD5	not available	INTSTD5	1 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	Female	Dementia with Lewy bodies	not available	4	13.5	22	not available	DLB5	2 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Parkinson's disease with dementia	not available	2	24	29	not available	PDD5	3 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	17.5	5	not available	AD5	4 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Dementia with Lewy bodies	not available	2	8	23	not available	DLB6	5 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	1	Dementia with Lewy bodies
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	Female	Control	not available	0	43	14	not available	Ctrl5	6 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Alzheimer's disease	not available	6	29	6	not available	AD6	7 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	1	Alzheimer's disease
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Female	Control	not available	2	6	15	not available	Ctrl6	8 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	1	Control
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	Male	Parkinson's disease with dementia	not available	0	32	30	not available	PDD6	9 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	1	Parkinson's disease with dementia
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD6	not available	INTSTD6	10 PXD006122-Sample-3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD7	not available	INTSTD7	1 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	5	44	7	not available	AD7	2 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	Male	Control	not available	1	42	16	not available	Ctrl7	3 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	Female	Control	not available	2	65	17	not available	Ctrl8	4 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Female	Dementia with Lewy bodies	not available	2	33.5	24	not available	DLB7	5 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	1	Dementia with Lewy bodies
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Parkinson's disease with dementia	not available	2	24	31	not available	PDD7	6 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	Female	Alzheimer's disease	not available	6	20.45	8	not available	AD8	7 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Parkinson's disease with dementia	not available	2	32	32	not available	PDD8	8 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	6	24	9	not available	AD9	9 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD8	not available	INTSTD8	10 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD7	not available	INTSTD7	1 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	5	44	7	not available	AD7	2 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	Male	Control	not available	1	42	16	not available	Ctrl7	3 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	Female	Control	not available	2	65	17	not available	Ctrl8	4 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Female	Dementia with Lewy bodies	not available	2	33.5	24	not available	DLB7	5 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	1	Dementia with Lewy bodies
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Parkinson's disease with dementia	not available	2	24	31	not available	PDD7	6 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	Female	Alzheimer's disease	not available	6	20.45	8	not available	AD8	7 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Parkinson's disease with dementia	not available	2	32	32	not available	PDD8	8 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	6	24	9	not available	AD9	9 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD8	not available	INTSTD8	10 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD7	not available	INTSTD7	1 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	5	44	7	not available	AD7	2 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	Male	Control	not available	1	42	16	not available	Ctrl7	3 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	Female	Control	not available	2	65	17	not available	Ctrl8	4 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Female	Dementia with Lewy bodies	not available	2	33.5	24	not available	DLB7	5 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	1	Dementia with Lewy bodies
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Parkinson's disease with dementia	not available	2	24	31	not available	PDD7	6 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	Female	Alzheimer's disease	not available	6	20.45	8	not available	AD8	7 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Parkinson's disease with dementia	not available	2	32	32	not available	PDD8	8 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	6	24	9	not available	AD9	9 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD8	not available	INTSTD8	10 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD7	not available	INTSTD7	1 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	5	44	7	not available	AD7	2 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	Male	Control	not available	1	42	16	not available	Ctrl7	3 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	Female	Control	not available	2	65	17	not available	Ctrl8	4 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Female	Dementia with Lewy bodies	not available	2	33.5	24	not available	DLB7	5 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	1	Dementia with Lewy bodies
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Parkinson's disease with dementia	not available	2	24	31	not available	PDD7	6 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	Female	Alzheimer's disease	not available	6	20.45	8	not available	AD8	7 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Parkinson's disease with dementia	not available	2	32	32	not available	PDD8	8 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	6	24	9	not available	AD9	9 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD8	not available	INTSTD8	10 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD7	not available	INTSTD7	1 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	5	44	7	not available	AD7	2 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	Male	Control	not available	1	42	16	not available	Ctrl7	3 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	Female	Control	not available	2	65	17	not available	Ctrl8	4 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Female	Dementia with Lewy bodies	not available	2	33.5	24	not available	DLB7	5 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	1	Dementia with Lewy bodies
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Parkinson's disease with dementia	not available	2	24	31	not available	PDD7	6 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	Female	Alzheimer's disease	not available	6	20.45	8	not available	AD8	7 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Parkinson's disease with dementia	not available	2	32	32	not available	PDD8	8 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	6	24	9	not available	AD9	9 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD8	not available	INTSTD8	10 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD7	not available	INTSTD7	1 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	5	44	7	not available	AD7	2 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	Male	Control	not available	1	42	16	not available	Ctrl7	3 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	Female	Control	not available	2	65	17	not available	Ctrl8	4 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Female	Dementia with Lewy bodies	not available	2	33.5	24	not available	DLB7	5 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	1	Dementia with Lewy bodies
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Parkinson's disease with dementia	not available	2	24	31	not available	PDD7	6 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	Female	Alzheimer's disease	not available	6	20.45	8	not available	AD8	7 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Parkinson's disease with dementia	not available	2	32	32	not available	PDD8	8 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	6	24	9	not available	AD9	9 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD8	not available	INTSTD8	10 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD7	not available	INTSTD7	1 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	5	44	7	not available	AD7	2 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	Male	Control	not available	1	42	16	not available	Ctrl7	3 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	Female	Control	not available	2	65	17	not available	Ctrl8	4 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Female	Dementia with Lewy bodies	not available	2	33.5	24	not available	DLB7	5 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	1	Dementia with Lewy bodies
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Parkinson's disease with dementia	not available	2	24	31	not available	PDD7	6 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	Female	Alzheimer's disease	not available	6	20.45	8	not available	AD8	7 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Parkinson's disease with dementia	not available	2	32	32	not available	PDD8	8 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	6	24	9	not available	AD9	9 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD8	not available	INTSTD8	10 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD7	not available	INTSTD7	1 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	5	44	7	not available	AD7	2 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	Male	Control	not available	1	42	16	not available	Ctrl7	3 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	Female	Control	not available	2	65	17	not available	Ctrl8	4 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Female	Dementia with Lewy bodies	not available	2	33.5	24	not available	DLB7	5 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	1	Dementia with Lewy bodies
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Parkinson's disease with dementia	not available	2	24	31	not available	PDD7	6 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	Female	Alzheimer's disease	not available	6	20.45	8	not available	AD8	7 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Parkinson's disease with dementia	not available	2	32	32	not available	PDD8	8 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	6	24	9	not available	AD9	9 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD8	not available	INTSTD8	10 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD7	not available	INTSTD7	1 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	5	44	7	not available	AD7	2 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	Male	Control	not available	1	42	16	not available	Ctrl7	3 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	Female	Control	not available	2	65	17	not available	Ctrl8	4 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Female	Dementia with Lewy bodies	not available	2	33.5	24	not available	DLB7	5 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	1	Dementia with Lewy bodies
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Parkinson's disease with dementia	not available	2	24	31	not available	PDD7	6 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	Female	Alzheimer's disease	not available	6	20.45	8	not available	AD8	7 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Parkinson's disease with dementia	not available	2	32	32	not available	PDD8	8 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	6	24	9	not available	AD9	9 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD8	not available	INTSTD8	10 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD7	not available	INTSTD7	1 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	5	44	7	not available	AD7	2 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	Male	Control	not available	1	42	16	not available	Ctrl7	3 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	Female	Control	not available	2	65	17	not available	Ctrl8	4 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Female	Dementia with Lewy bodies	not available	2	33.5	24	not available	DLB7	5 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	1	Dementia with Lewy bodies
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Parkinson's disease with dementia	not available	2	24	31	not available	PDD7	6 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	Female	Alzheimer's disease	not available	6	20.45	8	not available	AD8	7 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Parkinson's disease with dementia	not available	2	32	32	not available	PDD8	8 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	6	24	9	not available	AD9	9 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD8	not available	INTSTD8	10 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD7	not available	INTSTD7	1 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	5	44	7	not available	AD7	2 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	Male	Control	not available	1	42	16	not available	Ctrl7	3 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	Female	Control	not available	2	65	17	not available	Ctrl8	4 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Female	Dementia with Lewy bodies	not available	2	33.5	24	not available	DLB7	5 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	1	Dementia with Lewy bodies
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Parkinson's disease with dementia	not available	2	24	31	not available	PDD7	6 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	Female	Alzheimer's disease	not available	6	20.45	8	not available	AD8	7 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Parkinson's disease with dementia	not available	2	32	32	not available	PDD8	8 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	6	24	9	not available	AD9	9 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD8	not available	INTSTD8	10 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD7	not available	INTSTD7	1 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	5	44	7	not available	AD7	2 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	Male	Control	not available	1	42	16	not available	Ctrl7	3 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	Female	Control	not available	2	65	17	not available	Ctrl8	4 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Female	Dementia with Lewy bodies	not available	2	33.5	24	not available	DLB7	5 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	1	Dementia with Lewy bodies
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Parkinson's disease with dementia	not available	2	24	31	not available	PDD7	6 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	Female	Alzheimer's disease	not available	6	20.45	8	not available	AD8	7 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Parkinson's disease with dementia	not available	2	32	32	not available	PDD8	8 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	6	24	9	not available	AD9	9 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD8	not available	INTSTD8	10 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD7	not available	INTSTD7	1 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	5	44	7	not available	AD7	2 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	Male	Control	not available	1	42	16	not available	Ctrl7	3 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	Female	Control	not available	2	65	17	not available	Ctrl8	4 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Female	Dementia with Lewy bodies	not available	2	33.5	24	not available	DLB7	5 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	1	Dementia with Lewy bodies
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Parkinson's disease with dementia	not available	2	24	31	not available	PDD7	6 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	Female	Alzheimer's disease	not available	6	20.45	8	not available	AD8	7 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Parkinson's disease with dementia	not available	2	32	32	not available	PDD8	8 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	6	24	9	not available	AD9	9 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD8	not available	INTSTD8	10 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD7	not available	INTSTD7	1 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	5	44	7	not available	AD7	2 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	Male	Control	not available	1	42	16	not available	Ctrl7	3 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	Female	Control	not available	2	65	17	not available	Ctrl8	4 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Female	Dementia with Lewy bodies	not available	2	33.5	24	not available	DLB7	5 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	1	Dementia with Lewy bodies
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Parkinson's disease with dementia	not available	2	24	31	not available	PDD7	6 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	Female	Alzheimer's disease	not available	6	20.45	8	not available	AD8	7 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Parkinson's disease with dementia	not available	2	32	32	not available	PDD8	8 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	6	24	9	not available	AD9	9 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD8	not available	INTSTD8	10 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD7	not available	INTSTD7	1 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	5	44	7	not available	AD7	2 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	Male	Control	not available	1	42	16	not available	Ctrl7	3 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	Female	Control	not available	2	65	17	not available	Ctrl8	4 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Female	Dementia with Lewy bodies	not available	2	33.5	24	not available	DLB7	5 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	1	Dementia with Lewy bodies
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Parkinson's disease with dementia	not available	2	24	31	not available	PDD7	6 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	Female	Alzheimer's disease	not available	6	20.45	8	not available	AD8	7 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Parkinson's disease with dementia	not available	2	32	32	not available	PDD8	8 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	6	24	9	not available	AD9	9 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD8	not available	INTSTD8	10 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD7	not available	INTSTD7	1 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	5	44	7	not available	AD7	2 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	Male	Control	not available	1	42	16	not available	Ctrl7	3 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	Female	Control	not available	2	65	17	not available	Ctrl8	4 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Female	Dementia with Lewy bodies	not available	2	33.5	24	not available	DLB7	5 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	1	Dementia with Lewy bodies
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Parkinson's disease with dementia	not available	2	24	31	not available	PDD7	6 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	Female	Alzheimer's disease	not available	6	20.45	8	not available	AD8	7 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Parkinson's disease with dementia	not available	2	32	32	not available	PDD8	8 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	6	24	9	not available	AD9	9 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD8	not available	INTSTD8	10 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD7	not available	INTSTD7	1 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	5	44	7	not available	AD7	2 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	Male	Control	not available	1	42	16	not available	Ctrl7	3 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	Female	Control	not available	2	65	17	not available	Ctrl8	4 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Female	Dementia with Lewy bodies	not available	2	33.5	24	not available	DLB7	5 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	1	Dementia with Lewy bodies
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Parkinson's disease with dementia	not available	2	24	31	not available	PDD7	6 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	Female	Alzheimer's disease	not available	6	20.45	8	not available	AD8	7 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Parkinson's disease with dementia	not available	2	32	32	not available	PDD8	8 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	6	24	9	not available	AD9	9 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD8	not available	INTSTD8	10 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD7	not available	INTSTD7	1 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	5	44	7	not available	AD7	2 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	Male	Control	not available	1	42	16	not available	Ctrl7	3 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	Female	Control	not available	2	65	17	not available	Ctrl8	4 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Female	Dementia with Lewy bodies	not available	2	33.5	24	not available	DLB7	5 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	1	Dementia with Lewy bodies
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Parkinson's disease with dementia	not available	2	24	31	not available	PDD7	6 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	Female	Alzheimer's disease	not available	6	20.45	8	not available	AD8	7 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Parkinson's disease with dementia	not available	2	32	32	not available	PDD8	8 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	6	24	9	not available	AD9	9 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD8	not available	INTSTD8	10 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD7	not available	INTSTD7	1 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	5	44	7	not available	AD7	2 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	Male	Control	not available	1	42	16	not available	Ctrl7	3 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	Female	Control	not available	2	65	17	not available	Ctrl8	4 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Female	Dementia with Lewy bodies	not available	2	33.5	24	not available	DLB7	5 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	1	Dementia with Lewy bodies
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Parkinson's disease with dementia	not available	2	24	31	not available	PDD7	6 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	Female	Alzheimer's disease	not available	6	20.45	8	not available	AD8	7 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Parkinson's disease with dementia	not available	2	32	32	not available	PDD8	8 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	6	24	9	not available	AD9	9 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD8	not available	INTSTD8	10 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD7	not available	INTSTD7	1 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	5	44	7	not available	AD7	2 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	Male	Control	not available	1	42	16	not available	Ctrl7	3 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	Female	Control	not available	2	65	17	not available	Ctrl8	4 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Female	Dementia with Lewy bodies	not available	2	33.5	24	not available	DLB7	5 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	1	Dementia with Lewy bodies
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Parkinson's disease with dementia	not available	2	24	31	not available	PDD7	6 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	Female	Alzheimer's disease	not available	6	20.45	8	not available	AD8	7 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Parkinson's disease with dementia	not available	2	32	32	not available	PDD8	8 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	6	24	9	not available	AD9	9 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD8	not available	INTSTD8	10 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD7	not available	INTSTD7	1 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	5	44	7	not available	AD7	2 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	Male	Control	not available	1	42	16	not available	Ctrl7	3 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	Female	Control	not available	2	65	17	not available	Ctrl8	4 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Female	Dementia with Lewy bodies	not available	2	33.5	24	not available	DLB7	5 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	1	Dementia with Lewy bodies
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Parkinson's disease with dementia	not available	2	24	31	not available	PDD7	6 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	Female	Alzheimer's disease	not available	6	20.45	8	not available	AD8	7 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Parkinson's disease with dementia	not available	2	32	32	not available	PDD8	8 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	6	24	9	not available	AD9	9 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD8	not available	INTSTD8	10 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD7	not available	INTSTD7	1 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	5	44	7	not available	AD7	2 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	Male	Control	not available	1	42	16	not available	Ctrl7	3 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	Female	Control	not available	2	65	17	not available	Ctrl8	4 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Female	Dementia with Lewy bodies	not available	2	33.5	24	not available	DLB7	5 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	1	Dementia with Lewy bodies
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Parkinson's disease with dementia	not available	2	24	31	not available	PDD7	6 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	Female	Alzheimer's disease	not available	6	20.45	8	not available	AD8	7 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Parkinson's disease with dementia	not available	2	32	32	not available	PDD8	8 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	6	24	9	not available	AD9	9 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD8	not available	INTSTD8	10 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD7	not available	INTSTD7	1 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	5	44	7	not available	AD7	2 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	Male	Control	not available	1	42	16	not available	Ctrl7	3 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	Female	Control	not available	2	65	17	not available	Ctrl8	4 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Female	Dementia with Lewy bodies	not available	2	33.5	24	not available	DLB7	5 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	1	Dementia with Lewy bodies
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Parkinson's disease with dementia	not available	2	24	31	not available	PDD7	6 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	Female	Alzheimer's disease	not available	6	20.45	8	not available	AD8	7 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Parkinson's disease with dementia	not available	2	32	32	not available	PDD8	8 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	6	24	9	not available	AD9	9 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD8	not available	INTSTD8	10 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD7	not available	INTSTD7	1 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	5	44	7	not available	AD7	2 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	Male	Control	not available	1	42	16	not available	Ctrl7	3 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	Female	Control	not available	2	65	17	not available	Ctrl8	4 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Female	Dementia with Lewy bodies	not available	2	33.5	24	not available	DLB7	5 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	1	Dementia with Lewy bodies
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Parkinson's disease with dementia	not available	2	24	31	not available	PDD7	6 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	Female	Alzheimer's disease	not available	6	20.45	8	not available	AD8	7 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Parkinson's disease with dementia	not available	2	32	32	not available	PDD8	8 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	6	24	9	not available	AD9	9 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD8	not available	INTSTD8	10 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD7	not available	INTSTD7	1 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	5	44	7	not available	AD7	2 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	Male	Control	not available	1	42	16	not available	Ctrl7	3 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	Female	Control	not available	2	65	17	not available	Ctrl8	4 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Female	Dementia with Lewy bodies	not available	2	33.5	24	not available	DLB7	5 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	1	Dementia with Lewy bodies
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Parkinson's disease with dementia	not available	2	24	31	not available	PDD7	6 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	Female	Alzheimer's disease	not available	6	20.45	8	not available	AD8	7 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Parkinson's disease with dementia	not available	2	32	32	not available	PDD8	8 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	6	24	9	not available	AD9	9 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD8	not available	INTSTD8	10 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD7	not available	INTSTD7	1 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	5	44	7	not available	AD7	2 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	Male	Control	not available	1	42	16	not available	Ctrl7	3 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	Female	Control	not available	2	65	17	not available	Ctrl8	4 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Female	Dementia with Lewy bodies	not available	2	33.5	24	not available	DLB7	5 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	1	Dementia with Lewy bodies
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Parkinson's disease with dementia	not available	2	24	31	not available	PDD7	6 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	Female	Alzheimer's disease	not available	6	20.45	8	not available	AD8	7 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Parkinson's disease with dementia	not available	2	32	32	not available	PDD8	8 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	6	24	9	not available	AD9	9 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD8	not available	INTSTD8	10 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD7	not available	INTSTD7	1 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	5	44	7	not available	AD7	2 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	Male	Control	not available	1	42	16	not available	Ctrl7	3 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	Female	Control	not available	2	65	17	not available	Ctrl8	4 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Female	Dementia with Lewy bodies	not available	2	33.5	24	not available	DLB7	5 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	1	Dementia with Lewy bodies
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Parkinson's disease with dementia	not available	2	24	31	not available	PDD7	6 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	Female	Alzheimer's disease	not available	6	20.45	8	not available	AD8	7 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Parkinson's disease with dementia	not available	2	32	32	not available	PDD8	8 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	6	24	9	not available	AD9	9 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD8	not available	INTSTD8	10 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD7	not available	INTSTD7	1 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	5	44	7	not available	AD7	2 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	Male	Control	not available	1	42	16	not available	Ctrl7	3 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	Female	Control	not available	2	65	17	not available	Ctrl8	4 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Female	Dementia with Lewy bodies	not available	2	33.5	24	not available	DLB7	5 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	1	Dementia with Lewy bodies
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Parkinson's disease with dementia	not available	2	24	31	not available	PDD7	6 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	Female	Alzheimer's disease	not available	6	20.45	8	not available	AD8	7 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Parkinson's disease with dementia	not available	2	32	32	not available	PDD8	8 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	6	24	9	not available	AD9	9 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD8	not available	INTSTD8	10 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD7	not available	INTSTD7	1 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	5	44	7	not available	AD7	2 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	Male	Control	not available	1	42	16	not available	Ctrl7	3 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	Female	Control	not available	2	65	17	not available	Ctrl8	4 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Female	Dementia with Lewy bodies	not available	2	33.5	24	not available	DLB7	5 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	1	Dementia with Lewy bodies
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Parkinson's disease with dementia	not available	2	24	31	not available	PDD7	6 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	Female	Alzheimer's disease	not available	6	20.45	8	not available	AD8	7 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Parkinson's disease with dementia	not available	2	32	32	not available	PDD8	8 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	6	24	9	not available	AD9	9 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD8	not available	INTSTD8	10 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD7	not available	INTSTD7	1 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	5	44	7	not available	AD7	2 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	Male	Control	not available	1	42	16	not available	Ctrl7	3 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	Female	Control	not available	2	65	17	not available	Ctrl8	4 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Female	Dementia with Lewy bodies	not available	2	33.5	24	not available	DLB7	5 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	1	Dementia with Lewy bodies
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Parkinson's disease with dementia	not available	2	24	31	not available	PDD7	6 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	Female	Alzheimer's disease	not available	6	20.45	8	not available	AD8	7 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Parkinson's disease with dementia	not available	2	32	32	not available	PDD8	8 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	6	24	9	not available	AD9	9 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD8	not available	INTSTD8	10 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD7	not available	INTSTD7	1 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	5	44	7	not available	AD7	2 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	Male	Control	not available	1	42	16	not available	Ctrl7	3 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	Female	Control	not available	2	65	17	not available	Ctrl8	4 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Female	Dementia with Lewy bodies	not available	2	33.5	24	not available	DLB7	5 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	1	Dementia with Lewy bodies
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Parkinson's disease with dementia	not available	2	24	31	not available	PDD7	6 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	Female	Alzheimer's disease	not available	6	20.45	8	not available	AD8	7 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Parkinson's disease with dementia	not available	2	32	32	not available	PDD8	8 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	6	24	9	not available	AD9	9 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD8	not available	INTSTD8	10 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD7	not available	INTSTD7	1 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	5	44	7	not available	AD7	2 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	Male	Control	not available	1	42	16	not available	Ctrl7	3 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	Female	Control	not available	2	65	17	not available	Ctrl8	4 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Female	Dementia with Lewy bodies	not available	2	33.5	24	not available	DLB7	5 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	1	Dementia with Lewy bodies
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Parkinson's disease with dementia	not available	2	24	31	not available	PDD7	6 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	Female	Alzheimer's disease	not available	6	20.45	8	not available	AD8	7 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Parkinson's disease with dementia	not available	2	32	32	not available	PDD8	8 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	6	24	9	not available	AD9	9 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD8	not available	INTSTD8	10 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD7	not available	INTSTD7	1 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	5	44	7	not available	AD7	2 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	Male	Control	not available	1	42	16	not available	Ctrl7	3 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	Female	Control	not available	2	65	17	not available	Ctrl8	4 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Female	Dementia with Lewy bodies	not available	2	33.5	24	not available	DLB7	5 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	1	Dementia with Lewy bodies
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Parkinson's disease with dementia	not available	2	24	31	not available	PDD7	6 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	Female	Alzheimer's disease	not available	6	20.45	8	not available	AD8	7 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Parkinson's disease with dementia	not available	2	32	32	not available	PDD8	8 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	6	24	9	not available	AD9	9 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD8	not available	INTSTD8	10 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD7	not available	INTSTD7	1 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	5	44	7	not available	AD7	2 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	Male	Control	not available	1	42	16	not available	Ctrl7	3 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	Female	Control	not available	2	65	17	not available	Ctrl8	4 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Female	Dementia with Lewy bodies	not available	2	33.5	24	not available	DLB7	5 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	1	Dementia with Lewy bodies
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Parkinson's disease with dementia	not available	2	24	31	not available	PDD7	6 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	Female	Alzheimer's disease	not available	6	20.45	8	not available	AD8	7 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Parkinson's disease with dementia	not available	2	32	32	not available	PDD8	8 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	6	24	9	not available	AD9	9 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD8	not available	INTSTD8	10 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD7	not available	INTSTD7	1 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	5	44	7	not available	AD7	2 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	Male	Control	not available	1	42	16	not available	Ctrl7	3 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	Female	Control	not available	2	65	17	not available	Ctrl8	4 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Female	Dementia with Lewy bodies	not available	2	33.5	24	not available	DLB7	5 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	1	Dementia with Lewy bodies
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Parkinson's disease with dementia	not available	2	24	31	not available	PDD7	6 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	Female	Alzheimer's disease	not available	6	20.45	8	not available	AD8	7 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Parkinson's disease with dementia	not available	2	32	32	not available	PDD8	8 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	6	24	9	not available	AD9	9 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD8	not available	INTSTD8	10 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD7	not available	INTSTD7	1 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	5	44	7	not available	AD7	2 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	Male	Control	not available	1	42	16	not available	Ctrl7	3 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	Female	Control	not available	2	65	17	not available	Ctrl8	4 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Female	Dementia with Lewy bodies	not available	2	33.5	24	not available	DLB7	5 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	1	Dementia with Lewy bodies
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Parkinson's disease with dementia	not available	2	24	31	not available	PDD7	6 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	Female	Alzheimer's disease	not available	6	20.45	8	not available	AD8	7 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Parkinson's disease with dementia	not available	2	32	32	not available	PDD8	8 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	6	24	9	not available	AD9	9 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD8	not available	INTSTD8	10 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD7	not available	INTSTD7	1 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	5	44	7	not available	AD7	2 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	Male	Control	not available	1	42	16	not available	Ctrl7	3 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	Female	Control	not available	2	65	17	not available	Ctrl8	4 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Female	Dementia with Lewy bodies	not available	2	33.5	24	not available	DLB7	5 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	1	Dementia with Lewy bodies
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Parkinson's disease with dementia	not available	2	24	31	not available	PDD7	6 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	Female	Alzheimer's disease	not available	6	20.45	8	not available	AD8	7 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Parkinson's disease with dementia	not available	2	32	32	not available	PDD8	8 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	6	24	9	not available	AD9	9 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD8	not available	INTSTD8	10 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD7	not available	INTSTD7	1 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	5	44	7	not available	AD7	2 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	Male	Control	not available	1	42	16	not available	Ctrl7	3 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	Female	Control	not available	2	65	17	not available	Ctrl8	4 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Female	Dementia with Lewy bodies	not available	2	33.5	24	not available	DLB7	5 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	1	Dementia with Lewy bodies
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Parkinson's disease with dementia	not available	2	24	31	not available	PDD7	6 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	Female	Alzheimer's disease	not available	6	20.45	8	not available	AD8	7 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Parkinson's disease with dementia	not available	2	32	32	not available	PDD8	8 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	6	24	9	not available	AD9	9 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD8	not available	INTSTD8	10 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD7	not available	INTSTD7	1 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	5	44	7	not available	AD7	2 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	Male	Control	not available	1	42	16	not available	Ctrl7	3 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	Female	Control	not available	2	65	17	not available	Ctrl8	4 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Female	Dementia with Lewy bodies	not available	2	33.5	24	not available	DLB7	5 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	1	Dementia with Lewy bodies
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Parkinson's disease with dementia	not available	2	24	31	not available	PDD7	6 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	Female	Alzheimer's disease	not available	6	20.45	8	not available	AD8	7 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Parkinson's disease with dementia	not available	2	32	32	not available	PDD8	8 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	6	24	9	not available	AD9	9 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD8	not available	INTSTD8	10 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD7	not available	INTSTD7	1 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	5	44	7	not available	AD7	2 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	Male	Control	not available	1	42	16	not available	Ctrl7	3 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	Female	Control	not available	2	65	17	not available	Ctrl8	4 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Female	Dementia with Lewy bodies	not available	2	33.5	24	not available	DLB7	5 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	1	Dementia with Lewy bodies
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Parkinson's disease with dementia	not available	2	24	31	not available	PDD7	6 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	Female	Alzheimer's disease	not available	6	20.45	8	not available	AD8	7 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Parkinson's disease with dementia	not available	2	32	32	not available	PDD8	8 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	6	24	9	not available	AD9	9 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD8	not available	INTSTD8	10 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD7	not available	INTSTD7	1 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	5	44	7	not available	AD7	2 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	Male	Control	not available	1	42	16	not available	Ctrl7	3 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	Female	Control	not available	2	65	17	not available	Ctrl8	4 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Female	Dementia with Lewy bodies	not available	2	33.5	24	not available	DLB7	5 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	1	Dementia with Lewy bodies
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Parkinson's disease with dementia	not available	2	24	31	not available	PDD7	6 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	Female	Alzheimer's disease	not available	6	20.45	8	not available	AD8	7 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Parkinson's disease with dementia	not available	2	32	32	not available	PDD8	8 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	6	24	9	not available	AD9	9 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD8	not available	INTSTD8	10 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD7	not available	INTSTD7	1 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	5	44	7	not available	AD7	2 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	Male	Control	not available	1	42	16	not available	Ctrl7	3 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	Female	Control	not available	2	65	17	not available	Ctrl8	4 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Female	Dementia with Lewy bodies	not available	2	33.5	24	not available	DLB7	5 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	1	Dementia with Lewy bodies
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Parkinson's disease with dementia	not available	2	24	31	not available	PDD7	6 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	Female	Alzheimer's disease	not available	6	20.45	8	not available	AD8	7 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Parkinson's disease with dementia	not available	2	32	32	not available	PDD8	8 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	6	24	9	not available	AD9	9 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD8	not available	INTSTD8	10 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD7	not available	INTSTD7	1 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	5	44	7	not available	AD7	2 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	Male	Control	not available	1	42	16	not available	Ctrl7	3 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	Female	Control	not available	2	65	17	not available	Ctrl8	4 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Female	Dementia with Lewy bodies	not available	2	33.5	24	not available	DLB7	5 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	1	Dementia with Lewy bodies
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Parkinson's disease with dementia	not available	2	24	31	not available	PDD7	6 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	Female	Alzheimer's disease	not available	6	20.45	8	not available	AD8	7 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Parkinson's disease with dementia	not available	2	32	32	not available	PDD8	8 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	6	24	9	not available	AD9	9 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD8	not available	INTSTD8	10 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD7	not available	INTSTD7	1 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	5	44	7	not available	AD7	2 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	Male	Control	not available	1	42	16	not available	Ctrl7	3 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	Female	Control	not available	2	65	17	not available	Ctrl8	4 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Female	Dementia with Lewy bodies	not available	2	33.5	24	not available	DLB7	5 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	1	Dementia with Lewy bodies
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Parkinson's disease with dementia	not available	2	24	31	not available	PDD7	6 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	Female	Alzheimer's disease	not available	6	20.45	8	not available	AD8	7 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Parkinson's disease with dementia	not available	2	32	32	not available	PDD8	8 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	6	24	9	not available	AD9	9 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD8	not available	INTSTD8	10 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD7	not available	INTSTD7	1 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	5	44	7	not available	AD7	2 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	Male	Control	not available	1	42	16	not available	Ctrl7	3 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	Female	Control	not available	2	65	17	not available	Ctrl8	4 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Female	Dementia with Lewy bodies	not available	2	33.5	24	not available	DLB7	5 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	1	Dementia with Lewy bodies
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Parkinson's disease with dementia	not available	2	24	31	not available	PDD7	6 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	Female	Alzheimer's disease	not available	6	20.45	8	not available	AD8	7 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Parkinson's disease with dementia	not available	2	32	32	not available	PDD8	8 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	6	24	9	not available	AD9	9 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD8	not available	INTSTD8	10 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD7	not available	INTSTD7	1 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	5	44	7	not available	AD7	2 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	Male	Control	not available	1	42	16	not available	Ctrl7	3 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	Female	Control	not available	2	65	17	not available	Ctrl8	4 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Female	Dementia with Lewy bodies	not available	2	33.5	24	not available	DLB7	5 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	1	Dementia with Lewy bodies
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Parkinson's disease with dementia	not available	2	24	31	not available	PDD7	6 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	Female	Alzheimer's disease	not available	6	20.45	8	not available	AD8	7 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Parkinson's disease with dementia	not available	2	32	32	not available	PDD8	8 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	6	24	9	not available	AD9	9 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD8	not available	INTSTD8	10 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD7	not available	INTSTD7	1 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	5	44	7	not available	AD7	2 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	Male	Control	not available	1	42	16	not available	Ctrl7	3 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	Female	Control	not available	2	65	17	not available	Ctrl8	4 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Female	Dementia with Lewy bodies	not available	2	33.5	24	not available	DLB7	5 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	1	Dementia with Lewy bodies
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Parkinson's disease with dementia	not available	2	24	31	not available	PDD7	6 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	Female	Alzheimer's disease	not available	6	20.45	8	not available	AD8	7 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Parkinson's disease with dementia	not available	2	32	32	not available	PDD8	8 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	6	24	9	not available	AD9	9 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD8	not available	INTSTD8	10 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD7	not available	INTSTD7	1 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	5	44	7	not available	AD7	2 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	Male	Control	not available	1	42	16	not available	Ctrl7	3 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	Female	Control	not available	2	65	17	not available	Ctrl8	4 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Female	Dementia with Lewy bodies	not available	2	33.5	24	not available	DLB7	5 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	1	Dementia with Lewy bodies
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Parkinson's disease with dementia	not available	2	24	31	not available	PDD7	6 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	Female	Alzheimer's disease	not available	6	20.45	8	not available	AD8	7 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Parkinson's disease with dementia	not available	2	32	32	not available	PDD8	8 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	6	24	9	not available	AD9	9 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD8	not available	INTSTD8	10 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD7	not available	INTSTD7	1 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	5	44	7	not available	AD7	2 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	Male	Control	not available	1	42	16	not available	Ctrl7	3 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	Female	Control	not available	2	65	17	not available	Ctrl8	4 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Female	Dementia with Lewy bodies	not available	2	33.5	24	not available	DLB7	5 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	1	Dementia with Lewy bodies
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Parkinson's disease with dementia	not available	2	24	31	not available	PDD7	6 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	Female	Alzheimer's disease	not available	6	20.45	8	not available	AD8	7 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Parkinson's disease with dementia	not available	2	32	32	not available	PDD8	8 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	6	24	9	not available	AD9	9 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD8	not available	INTSTD8	10 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD7	not available	INTSTD7	1 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	5	44	7	not available	AD7	2 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	Male	Control	not available	1	42	16	not available	Ctrl7	3 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	Female	Control	not available	2	65	17	not available	Ctrl8	4 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Female	Dementia with Lewy bodies	not available	2	33.5	24	not available	DLB7	5 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	1	Dementia with Lewy bodies
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Parkinson's disease with dementia	not available	2	24	31	not available	PDD7	6 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	Female	Alzheimer's disease	not available	6	20.45	8	not available	AD8	7 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Parkinson's disease with dementia	not available	2	32	32	not available	PDD8	8 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	6	24	9	not available	AD9	9 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD8	not available	INTSTD8	10 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD7	not available	INTSTD7	1 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	5	44	7	not available	AD7	2 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	Male	Control	not available	1	42	16	not available	Ctrl7	3 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	Female	Control	not available	2	65	17	not available	Ctrl8	4 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Female	Dementia with Lewy bodies	not available	2	33.5	24	not available	DLB7	5 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	1	Dementia with Lewy bodies
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Parkinson's disease with dementia	not available	2	24	31	not available	PDD7	6 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	Female	Alzheimer's disease	not available	6	20.45	8	not available	AD8	7 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Parkinson's disease with dementia	not available	2	32	32	not available	PDD8	8 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	6	24	9	not available	AD9	9 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD8	not available	INTSTD8	10 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD7	not available	INTSTD7	1 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	5	44	7	not available	AD7	2 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	Male	Control	not available	1	42	16	not available	Ctrl7	3 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	Female	Control	not available	2	65	17	not available	Ctrl8	4 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Female	Dementia with Lewy bodies	not available	2	33.5	24	not available	DLB7	5 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	1	Dementia with Lewy bodies
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Parkinson's disease with dementia	not available	2	24	31	not available	PDD7	6 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	Female	Alzheimer's disease	not available	6	20.45	8	not available	AD8	7 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Parkinson's disease with dementia	not available	2	32	32	not available	PDD8	8 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	6	24	9	not available	AD9	9 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD8	not available	INTSTD8	10 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD7	not available	INTSTD7	1 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	5	44	7	not available	AD7	2 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	Male	Control	not available	1	42	16	not available	Ctrl7	3 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	Female	Control	not available	2	65	17	not available	Ctrl8	4 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Female	Dementia with Lewy bodies	not available	2	33.5	24	not available	DLB7	5 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	1	Dementia with Lewy bodies
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Parkinson's disease with dementia	not available	2	24	31	not available	PDD7	6 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	Female	Alzheimer's disease	not available	6	20.45	8	not available	AD8	7 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Parkinson's disease with dementia	not available	2	32	32	not available	PDD8	8 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	6	24	9	not available	AD9	9 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD8	not available	INTSTD8	10 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD7	not available	INTSTD7	1 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	5	44	7	not available	AD7	2 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	Male	Control	not available	1	42	16	not available	Ctrl7	3 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	Female	Control	not available	2	65	17	not available	Ctrl8	4 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Female	Dementia with Lewy bodies	not available	2	33.5	24	not available	DLB7	5 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	1	Dementia with Lewy bodies
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Parkinson's disease with dementia	not available	2	24	31	not available	PDD7	6 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	Female	Alzheimer's disease	not available	6	20.45	8	not available	AD8	7 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Parkinson's disease with dementia	not available	2	32	32	not available	PDD8	8 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	6	24	9	not available	AD9	9 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD8	not available	INTSTD8	10 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD7	not available	INTSTD7	1 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	5	44	7	not available	AD7	2 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	Male	Control	not available	1	42	16	not available	Ctrl7	3 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	Female	Control	not available	2	65	17	not available	Ctrl8	4 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Female	Dementia with Lewy bodies	not available	2	33.5	24	not available	DLB7	5 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	1	Dementia with Lewy bodies
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Parkinson's disease with dementia	not available	2	24	31	not available	PDD7	6 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	Female	Alzheimer's disease	not available	6	20.45	8	not available	AD8	7 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Parkinson's disease with dementia	not available	2	32	32	not available	PDD8	8 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	6	24	9	not available	AD9	9 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD8	not available	INTSTD8	10 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD7	not available	INTSTD7	1 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	5	44	7	not available	AD7	2 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	Male	Control	not available	1	42	16	not available	Ctrl7	3 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	Female	Control	not available	2	65	17	not available	Ctrl8	4 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Female	Dementia with Lewy bodies	not available	2	33.5	24	not available	DLB7	5 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	1	Dementia with Lewy bodies
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Parkinson's disease with dementia	not available	2	24	31	not available	PDD7	6 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	Female	Alzheimer's disease	not available	6	20.45	8	not available	AD8	7 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Parkinson's disease with dementia	not available	2	32	32	not available	PDD8	8 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	6	24	9	not available	AD9	9 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD8	not available	INTSTD8	10 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD7	not available	INTSTD7	1 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	5	44	7	not available	AD7	2 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	Male	Control	not available	1	42	16	not available	Ctrl7	3 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	Female	Control	not available	2	65	17	not available	Ctrl8	4 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Female	Dementia with Lewy bodies	not available	2	33.5	24	not available	DLB7	5 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	1	Dementia with Lewy bodies
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Parkinson's disease with dementia	not available	2	24	31	not available	PDD7	6 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	Female	Alzheimer's disease	not available	6	20.45	8	not available	AD8	7 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Parkinson's disease with dementia	not available	2	32	32	not available	PDD8	8 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	6	24	9	not available	AD9	9 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD8	not available	INTSTD8	10 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD7	not available	INTSTD7	1 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	5	44	7	not available	AD7	2 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	Male	Control	not available	1	42	16	not available	Ctrl7	3 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	Female	Control	not available	2	65	17	not available	Ctrl8	4 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Female	Dementia with Lewy bodies	not available	2	33.5	24	not available	DLB7	5 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	1	Dementia with Lewy bodies
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Parkinson's disease with dementia	not available	2	24	31	not available	PDD7	6 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	Female	Alzheimer's disease	not available	6	20.45	8	not available	AD8	7 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Parkinson's disease with dementia	not available	2	32	32	not available	PDD8	8 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	6	24	9	not available	AD9	9 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD8	not available	INTSTD8	10 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD7	not available	INTSTD7	1 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	5	44	7	not available	AD7	2 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	Male	Control	not available	1	42	16	not available	Ctrl7	3 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	Female	Control	not available	2	65	17	not available	Ctrl8	4 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Female	Dementia with Lewy bodies	not available	2	33.5	24	not available	DLB7	5 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	1	Dementia with Lewy bodies
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Parkinson's disease with dementia	not available	2	24	31	not available	PDD7	6 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	Female	Alzheimer's disease	not available	6	20.45	8	not available	AD8	7 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Parkinson's disease with dementia	not available	2	32	32	not available	PDD8	8 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	6	24	9	not available	AD9	9 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD8	not available	INTSTD8	10 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD7	not available	INTSTD7	1 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	5	44	7	not available	AD7	2 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	Male	Control	not available	1	42	16	not available	Ctrl7	3 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	Female	Control	not available	2	65	17	not available	Ctrl8	4 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Female	Dementia with Lewy bodies	not available	2	33.5	24	not available	DLB7	5 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	1	Dementia with Lewy bodies
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Parkinson's disease with dementia	not available	2	24	31	not available	PDD7	6 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	Female	Alzheimer's disease	not available	6	20.45	8	not available	AD8	7 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Parkinson's disease with dementia	not available	2	32	32	not available	PDD8	8 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	6	24	9	not available	AD9	9 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD8	not available	INTSTD8	10 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD7	not available	INTSTD7	1 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	5	44	7	not available	AD7	2 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	Male	Control	not available	1	42	16	not available	Ctrl7	3 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	Female	Control	not available	2	65	17	not available	Ctrl8	4 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Female	Dementia with Lewy bodies	not available	2	33.5	24	not available	DLB7	5 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	1	Dementia with Lewy bodies
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Parkinson's disease with dementia	not available	2	24	31	not available	PDD7	6 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	Female	Alzheimer's disease	not available	6	20.45	8	not available	AD8	7 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Parkinson's disease with dementia	not available	2	32	32	not available	PDD8	8 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	6	24	9	not available	AD9	9 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD8	not available	INTSTD8	10 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD7	not available	INTSTD7	1 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	5	44	7	not available	AD7	2 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	Male	Control	not available	1	42	16	not available	Ctrl7	3 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	Female	Control	not available	2	65	17	not available	Ctrl8	4 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Female	Dementia with Lewy bodies	not available	2	33.5	24	not available	DLB7	5 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	1	Dementia with Lewy bodies
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Parkinson's disease with dementia	not available	2	24	31	not available	PDD7	6 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	Female	Alzheimer's disease	not available	6	20.45	8	not available	AD8	7 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Parkinson's disease with dementia	not available	2	32	32	not available	PDD8	8 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	6	24	9	not available	AD9	9 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD8	not available	INTSTD8	10 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD7	not available	INTSTD7	1 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	5	44	7	not available	AD7	2 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	Male	Control	not available	1	42	16	not available	Ctrl7	3 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	Female	Control	not available	2	65	17	not available	Ctrl8	4 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Female	Dementia with Lewy bodies	not available	2	33.5	24	not available	DLB7	5 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	1	Dementia with Lewy bodies
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Parkinson's disease with dementia	not available	2	24	31	not available	PDD7	6 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	Female	Alzheimer's disease	not available	6	20.45	8	not available	AD8	7 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Parkinson's disease with dementia	not available	2	32	32	not available	PDD8	8 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	6	24	9	not available	AD9	9 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD8	not available	INTSTD8	10 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD7	not available	INTSTD7	1 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	5	44	7	not available	AD7	2 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	Male	Control	not available	1	42	16	not available	Ctrl7	3 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	Female	Control	not available	2	65	17	not available	Ctrl8	4 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Female	Dementia with Lewy bodies	not available	2	33.5	24	not available	DLB7	5 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	1	Dementia with Lewy bodies
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Parkinson's disease with dementia	not available	2	24	31	not available	PDD7	6 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	Female	Alzheimer's disease	not available	6	20.45	8	not available	AD8	7 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Parkinson's disease with dementia	not available	2	32	32	not available	PDD8	8 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	6	24	9	not available	AD9	9 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD8	not available	INTSTD8	10 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD7	not available	INTSTD7	1 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	5	44	7	not available	AD7	2 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	Male	Control	not available	1	42	16	not available	Ctrl7	3 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	Female	Control	not available	2	65	17	not available	Ctrl8	4 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Female	Dementia with Lewy bodies	not available	2	33.5	24	not available	DLB7	5 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	1	Dementia with Lewy bodies
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Parkinson's disease with dementia	not available	2	24	31	not available	PDD7	6 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	Female	Alzheimer's disease	not available	6	20.45	8	not available	AD8	7 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Parkinson's disease with dementia	not available	2	32	32	not available	PDD8	8 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	6	24	9	not available	AD9	9 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD8	not available	INTSTD8	10 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD7	not available	INTSTD7	1 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	5	44	7	not available	AD7	2 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	Male	Control	not available	1	42	16	not available	Ctrl7	3 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	Female	Control	not available	2	65	17	not available	Ctrl8	4 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Female	Dementia with Lewy bodies	not available	2	33.5	24	not available	DLB7	5 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	1	Dementia with Lewy bodies
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Parkinson's disease with dementia	not available	2	24	31	not available	PDD7	6 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	Female	Alzheimer's disease	not available	6	20.45	8	not available	AD8	7 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Parkinson's disease with dementia	not available	2	32	32	not available	PDD8	8 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	6	24	9	not available	AD9	9 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD8	not available	INTSTD8	10 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD7	not available	INTSTD7	1 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	5	44	7	not available	AD7	2 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	Male	Control	not available	1	42	16	not available	Ctrl7	3 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	Female	Control	not available	2	65	17	not available	Ctrl8	4 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Female	Dementia with Lewy bodies	not available	2	33.5	24	not available	DLB7	5 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	1	Dementia with Lewy bodies
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Parkinson's disease with dementia	not available	2	24	31	not available	PDD7	6 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	Female	Alzheimer's disease	not available	6	20.45	8	not available	AD8	7 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Parkinson's disease with dementia	not available	2	32	32	not available	PDD8	8 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	6	24	9	not available	AD9	9 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD8	not available	INTSTD8	10 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD7	not available	INTSTD7	1 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	5	44	7	not available	AD7	2 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	Male	Control	not available	1	42	16	not available	Ctrl7	3 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	Female	Control	not available	2	65	17	not available	Ctrl8	4 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Female	Dementia with Lewy bodies	not available	2	33.5	24	not available	DLB7	5 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	1	Dementia with Lewy bodies
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Parkinson's disease with dementia	not available	2	24	31	not available	PDD7	6 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	Female	Alzheimer's disease	not available	6	20.45	8	not available	AD8	7 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Parkinson's disease with dementia	not available	2	32	32	not available	PDD8	8 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	6	24	9	not available	AD9	9 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD8	not available	INTSTD8	10 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD7	not available	INTSTD7	1 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	5	44	7	not available	AD7	2 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	Male	Control	not available	1	42	16	not available	Ctrl7	3 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	Female	Control	not available	2	65	17	not available	Ctrl8	4 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Female	Dementia with Lewy bodies	not available	2	33.5	24	not available	DLB7	5 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	1	Dementia with Lewy bodies
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Parkinson's disease with dementia	not available	2	24	31	not available	PDD7	6 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	Female	Alzheimer's disease	not available	6	20.45	8	not available	AD8	7 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Parkinson's disease with dementia	not available	2	32	32	not available	PDD8	8 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	6	24	9	not available	AD9	9 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD8	not available	INTSTD8	10 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD7	not available	INTSTD7	1 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	5	44	7	not available	AD7	2 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	Male	Control	not available	1	42	16	not available	Ctrl7	3 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	Female	Control	not available	2	65	17	not available	Ctrl8	4 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Female	Dementia with Lewy bodies	not available	2	33.5	24	not available	DLB7	5 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	1	Dementia with Lewy bodies
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Parkinson's disease with dementia	not available	2	24	31	not available	PDD7	6 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	Female	Alzheimer's disease	not available	6	20.45	8	not available	AD8	7 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Parkinson's disease with dementia	not available	2	32	32	not available	PDD8	8 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	6	24	9	not available	AD9	9 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD8	not available	INTSTD8	10 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD7	not available	INTSTD7	1 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	5	44	7	not available	AD7	2 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	Male	Control	not available	1	42	16	not available	Ctrl7	3 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	Female	Control	not available	2	65	17	not available	Ctrl8	4 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Female	Dementia with Lewy bodies	not available	2	33.5	24	not available	DLB7	5 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	1	Dementia with Lewy bodies
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Parkinson's disease with dementia	not available	2	24	31	not available	PDD7	6 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	Female	Alzheimer's disease	not available	6	20.45	8	not available	AD8	7 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Parkinson's disease with dementia	not available	2	32	32	not available	PDD8	8 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	6	24	9	not available	AD9	9 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD8	not available	INTSTD8	10 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD7	not available	INTSTD7	1 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	1	Global Internal Standard
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	5	44	7	not available	AD7	2 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	Male	Control	not available	1	42	16	not available	Ctrl7	3 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	Female	Control	not available	2	65	17	not available	Ctrl8	4 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	1	Control
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	Female	Dementia with Lewy bodies	not available	2	33.5	24	not available	DLB7	5 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	1	Dementia with Lewy bodies
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Male	Parkinson's disease with dementia	not available	2	24	31	not available	PDD7	6 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	Female	Alzheimer's disease	not available	6	20.45	8	not available	AD8	7 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Parkinson's disease with dementia	not available	2	32	32	not available	PDD8	8 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	1	Parkinson's disease with dementia
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	Female	Alzheimer's disease	not available	6	24	9	not available	AD9	9 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	1	Alzheimer's disease
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Global Internal Standard	not available	not available	not available	INTSTD8	not available	INTSTD8	10 PXD006122-Sample-4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	1	Global Internal Standard